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The mechanism mediating nuclear translocation of the apoptosis inducing factor (AIF) 
 
Abstract 
 
 Since the discovery that yeast cells can undergo programmed cell death in response to 
several different stimuli, Saccharomyces cerevisiae has gained prominence in the cell death 
field. Exposure of yeast cells to certain stimuli like acetic acid or hydrogen peroxide or even 
heterologous expression of pro-apoptotic proteins can trigger cell death by apoptosis via a 
mitochondrial pathway and exhibiting the typical hallmarks of apoptosis, such as chromatin 
condensation, ROS (reactive oxygen species) accumulation, DNA fragmentation, 
externalization of phosphatidylserine, mitochondrial dysfunction with release of cytochrome c 
and of apoptosis inducing factor (Aif1p), among other pro-apoptotic proteins.  
 Aif1p is a flavoprotein that is involved both in cell survival and cell death. In healthy 
cells, Aif1p is confined to the mitochondria, where it plays a role in bioenergetic and redox 
metabolism due to its redox activity and its FAD and NADH domains. However, when cells are 
exposed to an apoptotic stimulus, Aif1p is released from mitochondria to the cytosol and then 
translocated to the nucleus, where it will induce DNA fragmentation and chromatin 
condensation. Although the mechanism underlying this translocation is still poorly understood, it 
is known that transport into the nucleus through the nuclear pore complexes is an energy-
dependent process for the majority of macromolecules, and normally mediated by the major 
class of transport receptors, the karyopherins or Kaps. In this work, we aimed elucidate the 
mechanism regulating yeast Aif1p import into the nucleus and to discover which Kap is 
responsible for the nuclear import of Aif1p. 
 Apoptosis was triggered in cells expressing Aif1p tagged with GFP (by exposure to 
acetic acid or hydrogen peroxide, chronological ageing, or heterologous expression of Bax c-
myc protein) and Aif1p localization was assessed by fluorescence microscopy and cellular 
fractionation/western blot assays. However, we were not able to observe the release of Aif1p to 
the cytosol or its nuclear import under our experimental conditions. We also attempted to map 
the NLS domain of Aif1p by deletion of several domains with homology to previously mapped 
domains in human AIF. Although we has not yet mapped the Aif1p NLS domain, we discovered 
that deletion of the putative Hsp70p-binding domain led to aberrant localization of Aif1p, 
suggesting that Hsp70p is important for Aif1p folding and stability. These results indicate that 
Hsp70p may also be involved in the regulation of Aif1p localization in yeast. 
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Mecanismo mediador da translocação nuclear do fator de indução de apoptose (AIF) 
 
Resumo 
 
 Células de Saccharomyces cerevisiae são capazes de desencadear um processo de 
morte celular programada em resposta a vários estímulos. Esta descoberta levou à utilização 
extensiva deste organismo eucarionte unicelular como modelo no estudo de processos de 
morte celular. Sabe-se que a exposição de células de levedura a certos estímulos, como o 
ácido acético ou peróxido de hidrogénio, ou mesmo a expressão heteróloga de proteínas pró-
apoptóticas de mamífero, pode desencadear um tipo morte celular dependente de uma via 
mitocondrial e exibindo características típicas da morte apoptótica, tais como a condensação 
da cromatina, acumulação de espécies reativas de oxigénio (ROS), fragmentação do DNA, 
externalização de fosfatidilserina e disfunção mitocondrial associada à libertação de citocromo 
c e do fator indutor de apoptose (Aif1p). 
 Aif1p é uma flavoproteína que está envolvida tanto na sobrevivência como na morte 
celular. Em células saudáveis, esta proteína está confinada à mitocôndria, onde desempenha 
um importante papel no metabolismo bioenergético e estado redox. Este facto é devido à sua 
atividade redox e aos seus domínios FAD e NADH. No entanto, em células expostas a um 
estímulo apoptótico, ocorre libertação de Aif1p da mitocôndria para o citosol e 
subsequentemente a sua translocação para o núcleo, onde induz fragmentação do DNA e 
condensação da cromatina. Embora o mecanismo subjacente a esta translocação esteja ainda 
pouco conhecido e estudado, sabe-se que para a maioria das macromoléculas o transporte 
para o núcleo ocorre através dos complexos de poros nucleares e é um processo dependente 
de energia, normalmente mediado por uma classe de recetores de transporte, as Kaps (do 
inglês “karyopherins”, também conhecidas como importinas ou transportinas). Este trabalho 
teve como objectivo elucidar a regulação do mecanismo de transporte de Aif1p para o núcleo e 
identificar que/ais Kap(s) são responsáveis pelo importe do Aif1p para o núcleo na levedura. 
 A morte celular apoptótica foi induzida em células que expressam uma fusão da 
proteína Aif1 com GFP (por exposição a ácido acético ou peróxido de hidrogénio, 
envelhecimento cronológico, ou pela expressão heteróloga de proteínas Bax c-myc) e a 
localização de Aif1p foi avaliada por microscopia de fluorescência e fracionamento celular 
/western Blot. No entanto, não fomos capazes de observar libertação de Aif1p para o citosol ou 
a sua importação nuclear nas condições experimentais utilizadas. Tentámos também mapear o 
domínio NLS de Aif1p através da remoção de vários domínios homólogos com domínios 
conhecidos de AIF humano. Embora não tenhamos ainda conseguido mapear o domínio NLS 
do Aif1p, descobrimos que a deficiência no domínio putativo de ligação a Hsp70 resulta numa 
localização aberrante de Aif1p, sugerindo que a Hsp70 é importante para a estabilidade desta 
proteína e que esta proteína pode ainda estar envolvida na regulação da localização de Aif1p 
na levedura. 
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1.1. Apoptosis  
 
 Multicellular organisms often need to eliminate cells that are in excess, or 
damaged cells that can put the organism at risk (Hengartner, 2000). To this end, they 
use a highly regulated and complex process characterized by a group of endogenous 
molecular events that culminates in “cell suicide” (Leist et al., 2001), designated by 
programmed cell death (PCD). Several types of cell death have been associated with 
PCD, but in eukaryotic cells the most common is apoptosis (Hengartner, 2000). 
Apoptosis occurs during normal development of multicellular organisms and continues 
through adult life. This process is as important as cell division or cell migration because 
it allows the organism to control cell number and tissue size, as well as protect itself 
from compromised cells that can threaten homeostasis, such as infected or damaged 
cells (Gewies, 2003). 
 The term apoptosis derives from the Greek “apo” - from and “ptosis” – falling, an 
analogy to the term used by Greeks to describe leaves falling from trees. This term was 
used in 1972 by John Kerr and colleagues to describe a type of cell death with distinct 
morphologic characteristics (Lawen, 2003). Indeed, apoptotic cells can easily be 
recognized by several morphological features such as cell shrinking, chromatin 
condensation and migration along the nuclear membrane, blebbing of the plasma 
membrane and exposure of phosphatidylserine to the outer leaflet of the plasma 
membrane. The final hallmark of apoptosis is cell fragmentation into compact 
structures, called 'apoptotic bodies' that will be phagocyted by macrophages and 
eliminated from the tissue without leading to an inflammatory response (Saraste et al., 
2000).  
 
1.1.1. Mechanism of apoptosis 
 
 Apoptosis can be triggered by various stimuli and mechanisms, including virus 
infection, cell stress and DNA damage. Cellular sensitivity to these stimuli can differ 
depending on several factors, such as expression of anti- and pro-apoptotic proteins, 
the harshness of the stimulus and the phase of the cell cycle (Gewies, 2003). The 
apoptotic process consists of three consecutive steps: (i) a trigger by extracellular or 
intracellular stimuli; (ii) execution by activation of intracellular proteases and (iii) 
elimination of dead cells by engulfment of cell debris by neighboring cells or 
macrophages (Saikumar et al., 1999). Deficient regulation of apoptosis can lead to 
various pathologies (Rudin and Thompson, 1997); improper activation may cause or 
contribute to several diseases such as ischemic strokes, AIDS (acquired 
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immunodeficiency syndrome), and several neurodegenerative disorders (Raff et al., 
1993, Ameisen et al., 1995 and Smale et al., 1995). In contrast, a flawed activation of 
this process can lead to some autoimmune diseases and to uncontrolled cell division 
that culminates in the development of cancers (Tan, 1994; Lowe and Lin, 2000 and 
Reed, 2003). 
 Two major apoptotic pathways have been identified in mammalian cells: the 
extrinsic or death receptor pathway and the intrinsic or mitochondrial pathway (Figure 
1) (Hengatner 2000 and Elmore, 2007). 
 
1.1.1.1. Extrinsic pathway 
 
 In the extrinsic pathway, “death receptors” are activated to transmit apoptotic 
signals from the exterior to the interior of cells. Examples of death receptors are TNFR-
1, Fas/CD95 and TRAIL receptors. Death receptors belonging to the tumor necrosis 
factor receptor (TNFR) gene superfamily are present in the cell surface and transmit 
the apoptotic signal after ligation of precise ligands such as Fas ligand, TNF alpha and 
TRAIL. They have an important role in apoptosis because they can trigger a caspase 
cascade within seconds of ligand binding and induce apoptosis very quickly (Sartorius 
et al., 2001). 
 Caspases (Cysteine-dependent Aspartate-specific Proteases) are conserved 
through evolution and can be found in several organisms such as insects, human, 
hydra and nematodes (Cohen, 1997). They are synthesized as inactive zymogens, 
named procaspases. They have a prodomain followed by a small and a large subunit 
that are occasionally separated by a linker peptide. After maturation, procaspases are 
proteolytically processed between the large and the small subunit. An active caspase is 
a heterotetramer that consists of two large and two small subunits (Hengartner, 2000). 
Their active site contains a cysteine residue critical for catalytic activity; it has high 
affinity for aspartate residues, after which caspases cleave their substrates. So far, 
about a hundred caspases substrates have been described (Fischer et al., 2003).  
 There are two different groups of caspases: (i) initiator caspases, which include 
the procaspases -2, -8, -9 and –10, with long prodomains such as death effector 
domains (DED) in procaspase-8 and -10 or caspase recruitment domains (CARD) in 
procaspases-9 and -2; (ii) effector or executioner caspases, with only short 
prodomains, which include procaspases -3, -6 and -7 (Chrowdhury et al., 2008). 
 In the extrinsic pathway, initiation of apoptosis requires both caspases and 
death receptors. Apoptotic signaling is mediated by the death domain (DD) of the death 
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receptor. Adapter molecules that possess their own DDs, as FADD or TRADD, are 
then recruited to the DDs of the death receptor to form the death-inducing signaling 
complex (DISC). With the help of FADD, procaspase 8 (initiator procaspase) is then 
recruited to the DISC, and the amount of procaspase-8 molecules in the DISC leads to 
their autocatalytic activation and consequent release of active caspase-8. Active 
caspase-8 then activates the caspase signaling cascade; subsequently, effector 
caspases cleave specific substrates, resulting in cell death (Stegh et al., 1998; Scaffidi 
et al., 1998). It is possible to inhibit caspase-8 in order to protect cells from apoptosis. 
One example is cellular-FLICE (FADD-like IL-1β-converting enzyme)-inhibitory protein 
(c-FLIP), which can inhibit DISC signaling. This inhibition will lead to inactivation of 
DISC and by consequence inhibition of the extrinsic pathway (Hengartner, 2000). In 
some cases, the apoptotic signal produced by death receptors might not be capable of 
inducing a caspase signaling cascade strong enough to lead to cell death on its own. In 
other cases, there may be a bridge between the caspase signaling cascade and 
mitochondria provided by Bid, a Bcl-2 family member (see below). Bid can be cleaved 
into its truncated form (tBID) by caspase-8 and translocated to the mitochondria, where 
it induces the release of pro-apoptotic proteins to the cytosol (Luo et al., 1998 and 
Gustafsson et al., 2007).  
 
1.1.1.2. Intrinsic pathway 
 
 The intrinsic pathway is triggered by “intrinsic” stresses such as DNA damage, 
endoplasmic reticulum stress, lysosomal stress, and mitochondrial dysfunction. In 
contrast with the extrinsic pathway, in which caspases are activated directly, the 
intrinsic pathway requires the participation of mitochondria. Permeabilization of the 
outer mitochondrial membrane (MOMP) and the release of pro-apoptotic factors are 
crucial events of the intrinsic pathway and required for activation the downstream 
caspase cascade. Mitochondria have thus gained great importance in the field of 
mammalian apoptosis, since they are able to amplify the apoptotic signal from the 
extrinsic pathway and also propagate the death signals generated within the cell, such 
as oxidative stress, DNA damage and others (Wang, 2001). 
  The Bcl-2 family, a group of apoptotic regulators with both anti- and pro-
apoptotic members, plays a major role in the regulation of the intrinsic pathway. Bcl-2 
family members share homologous regions known as BH domains, and can be divided 
into four categories based on structural and functional similarities, namely: i) the anti-
apoptotic Bcl-2 proteins (A1, Bcl-2, Bcl-w, Bcl-xL and Mcl-1); ii) Bcl-2 effector proteins 
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(Bax and Bak); iii) direct activator BH3-only proteins (Bid, Bim and Puma) and iv) 
sensitizer/derepressor proteins (Bad, Bik, Bmf, Hrk and Noxa) (Chipuk et al., 2010). 
Pro- and anti-apoptotic proteins can interact with each other and with several other 
proteins, forming several regulatory networks, and is the balance of the levels of pro- 
and anti-apoptotic proteins that can dictate the fate of the cell, mainly through 
regulation of MOMP. 
 
 
 
 
Figure 1 - Schematic representation of the extrinsic and intrinsic pathways involved in apoptosis 
(Hengatner 2000). 
 
 Mitochondria are surrounded by two membranes, the inner mitochondrial 
membrane (IMM) and the outer mitochondrial membrane (OMM), which divide the 
mitochondria into two compartments: the intermembrane space (IMS) between the 
membranes, and the inner compartment called the matrix. Many stress stimuli can 
trigger permeabilization and release of pro-apoptotic proteins from the mitochondria to 
the cytosol. Two main hypotheses explaining how permeabilization of mitochondria 
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occurs have been put forth. The first hypothesis suggests that a transmembrane 
channel named the permeability transition pore (PTP) is formed on the contact sites 
between the IMM and the OMM. These pores are thought to be mainly constituted by 
VDAC in the OMM and by adenine nucleotide translocator (ANT) in the IMM. PTP 
opening results in loss of membrane potential, uptake of solutes and entry of water to 
the matrix, leading to the rupture of the outer membrane and release of pro-apoptotic 
proteins from the IMS to the cytoplasm (Lawen, 2003). Another hypothesis is based on 
the ability of the pro-apoptotic Bcl-2 proteins to form pores. Indeed, the accepted model 
proposes a stepwise structural reorganization of Bax leading to mitochondrial targeting 
and homo-oligomerization. Bax is kept as a monomeric soluble cytosolic factor through 
the engagement of its α9 helix in the dimerization pocket by the α1 helix. The activator 
BH3s, tBID/BIM/PUMA, attack and expose the α1 helix of Bax, leading to a secondary 
disconnection of the α9 helix and consequently mitochondrial insertion. Activator BH3s 
stay associated with the N-terminally exposed Bax through the BH1 domain to drive 
homo-oligomerization and activation of Bax (Ren et al., 2010). 
  Permeabilization of mitochondria results in the release of several proteins such 
as cytochrome c, Omi/HtrA2 (High Temperature Requirement Protein A2) and 
Smac/DIABLO (Second Mitochondria-derived Activator of Caspases/Direct Inhibitor of 
Apoptosis Protein (IAP)-binding Protein With Low pI). Later, the apoptosis inducing 
factor (AIF) and endonuclease G (EndoG) are also released. All these proteins are 
located in the mitochondrial intermembrane space (IMS) and are released to the 
cytosol in response to several apoptotic stimuli, such as extra- and intracellular 
stresses like oxidative stress and treatment with cytotoxic drugs (Vaux, 2011). Proteins 
of the first group activate the caspase-dependent mitochondrial pathway. After its 
release to the cytosol, cytochrome c can interact with Apaf-1 (Protease Activating 
Factor – 1), leading to the recruitment of pro-caspase 9, which together with dATP 
forms a multi-protein complex, the apoptosome, which in turn activates caspase -9 
leading to apoptosis. On the other hand, Smac and Omi/HtrA2 normally neutralize IAP 
(Inhibitors of Apoptosis Proteins), which normally inhibit effector caspases. Pro-
apoptotic proteins of the second group are released only after the cell has committed to 
die. Both AIF and Endo G are translocated to the nucleus (Joza et al., 2001). AIF 
induces DNA fragmentation and chromatin condensation, whereas Endo G induces 
DNA internucleossomal fragmentation (Wang, 2001). 
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1.2. Apoptosis inducing factor (AIF) 
 
 The mammalian mitochondrial AIF is a flavoprotein that belongs to a larger 
family of proteins with common structural and functional features, containing bacterial, 
plant and fungal oxidoreductases. It is a protein with 613 aminoacids and is structurally 
divided into three typical domains: a FAD and a NADH binding domain and a C-
terminal domain, where its pro-apoptotic activity resides. In addition, it also possesses 
an N-terminal MLS (Mitochondria Localization Signal) (Figure 2) (Gurbuxani et al., 
2003). Besides AIF, AIF homologous mitochondrion-associated inducer of death 
(AMID) and AIF-Like (AIFL) also belong to this family (Hangen et al., 2010). 
 
 
 
 
Figure 2 – Representation of the three different AIF forms: the precursor, the mature and the truncated 
AIF. AIF contains an N-terminal MLS domain (green), a FAD bipartite domain (yellow), an NADH binding 
domain (violet) and a C-terminal domain (red). It also possesses an Hsp70p and a Cyclophilin A binding 
domain. Cleavage at the MPP (Mitochondrial Processing Peptidase) cleavage site (blue dotted line) 
generates mitochondrial mature AIF and cleavage by calpains (at the red dotted line) generates truncated 
AIF (tAIF) (Yuste et al., 2007).  
 
 In healthy cells, AIF is confined to mitochondria, where it plays an important role 
in bioenergetic and redox metabolism. However, after an apoptotic stimulus, AIF is 
released from mitochondria to the cytosol and translocated into the nucleus 
(Modjtahedi et al., 2006). 
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1.2.1. The role of AIF in cells 
 
 AIF has dual functions, in DNA fragmentation and in redox activity, and thus 
acts both in cell death and cell survival. However, biochemical and mutational analysis 
of AIF suggests that its apoptotic and redox functions can be separated (Lipton et al., 
2002). Three distinct functions have been associated with AIF, as seen in figure 3.  
 
 
 
 
 
Figure 3 - Representation of the three different functions of AIF in cells. First, AIF has a role as an NADH 
oxidase. Second, cytosolic AIF seems to promote mitochondrial membrane permeabilization and third, AIF 
can promote chromatin condensation and DNA fragmentation (Candé et al., 2002). 
  
 The first function attributed to AIF is it NADH oxidase activity. AIF has a redox 
potential of –308 mV ± 15 mV at pH 7.5. It has monodehydroascorbate reductase 
activity and catalyses cytochrome c reduction in the presence of NADH. Results have 
shown that the AIF NADH oxidase activity requires an electron donor (NADH), an 
electron acceptor and a prosthetic FAD group for catalytic electron transfer (Miramar et 
al., 2001). 
 The second function is permeabilization of the mitochondrial membrane and 
consequent release of cytocrome c and additional AIF. This function is attributed to 
cytosolic AIF, since studies revealed that when AIF is introduced into the cytosol it can 
induce the release of AIF and cytochrome c from mitochondria (Daugas et al., 2000). 
When cells commit to apoptosis, AIF translocates to the nucleus, where it exerts its 
third function: to trigger cell death by promoting chromatin condensation and DNA 
fragmentation (Candé et al., 2002). Several reports suggest that this role of AIF in the 
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nucleus functions as a backup to caspase-dependent mechanisms. However, it was 
also described that AIF-induced cell death occurs in the complete absence of caspases 
and the oxireductase activation. AIF seems to play a role in caspase-independent PCD 
in several organisms such as Caenorhabditis elegans, Dyctiostelium discoideum and 
mammals (Arnoult et al., 2001, Wang et al., 2007, Wang et al., 2002 and Lorenzo et 
al., 2007).  
 But how are these effects achieved at the molecular level? The crystal structure 
of AIF shows that the surface of the protein has positively charged amino acids, 
allowing it to form electrostatic connections with DNA. AIF binds with more affinity to 
linearized forms than to intact circular plasmids, suggesting that it is introduced into the 
DNA strand breaks. The AIF-DNA interaction is accompanied by DNA condensation 
(shortening of the DNA), hairpin formation (intermolecular packageing) and DNA 
oligomerization (Modjtahedi et al., 2006). Studies have shown that addition of AIF to 
DNA does not cause DNA degradation. It was therefore suggested that after entering 
the nucleus AIF can cooperate with several exo- and endonucleases, building up a so-
called “degradeosome” including cyclophilins, proteins belonging to the family of 
peptidylprolyl cis–trans isomerases. Human AIF is able to interact with cyclophilin A 
(CypA) and forms an active DNase, and several studies confirm that CypA is essential 
for the apoptotic activity of AIF (Candé et al., 2004). These characteristics can be 
included into a hypothetical model: AIF invades DNA strand-breaks, induces DNA 
condensation and finally participates in the formation of a DNA-degrading polyprotein 
complex (Figure 4). It is still not known if the deadly effect of the translocation of AIF to 
the nucleus is due to inhibition of the respiratory chain or to apoptotic DNA degradation 
in the nucleus. 
 It has recently been discovered that AIF acts in programmed necrosis, in 
addition to its involvement in apoptotic PCD.  PCD is a dynamic process that depends 
on the characteristics of the involving scenario, such as cell or tissue type, death 
stimulus or environmental conditions. Cells can use caspase or non-caspase 
dependent mechanisms, exhibiting necrotic or apoptotic features. Programmed 
necrosis is thus an active capase-independent pathway. Moubarak et al. described that 
AIF is a regulator of this type of PCD by causing extensive DNA damage when cells 
are exposed to high doses of MNNG, an alkylating agent and necrotic inducer. In this 
study, AIF knockout protected cells from DNA damage and cell death, highlighting the 
requirement of this protein for programmed necrosis (Moubarak et al., 2007, Boujrad et 
al., 2007 and Schabel, 1976). 
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Figure 4 - Hypothesized model for the action of AIF on DNA (Modjtahedi et al, 2006). 
 
1.2.2. The mechanism underlying AIF release from mitochondria  
 
 AIF is encoded by a nuclear gene and is synthesized in the cytoplasm. It is 
imported to mitochondria through the general import pathway as a 67 kDa protein with 
a mitochondrial localization signal (MLS) in the N-terminus and anchored to the IMM. 
Upon import to the mitochondria IMS, the MLS is cleaved by a mitochondrial peptidase 
to generate mature 62 kDa AIF. As referred above, after treatment with certain 
apoptotic stimuli, AIF can be cleaved from its membrane anchor by proteases (calpains 
and cathepsins), forming a soluble 57 kDa AIF fragment (Figure 2). Calpains are a 
family of calcium-dependent cysteine proteases. There are two main isoforms, calpain-I 
and calpain-II, which co-exist with the calpain-specific inhibitor calpastatin. The 
interaction between the two prevents both activation and catalytic activity of calpains. 
Their localization is uncertain, but recently calpain was found to contain an MLS and it 
was suggested that calpains are present in the mitochondrial IMS. Upon activation, 
calpains can cleave and destroy calpastatin that, with addition of Ca2+ to the 
mitochondria, is sufficient to stimulate AIF cleavage, as illustrated in figure 5 (Badugu 
et al., 2008 and Norberg et al., 2010). 
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Figure 5 - Schematic representation of the mechanism behind the release of AIF from IMM to the 
cytoplasm (Norberg et al., 2010).  
 
1.2.3. Heat shock protein 70 (Hsp70p) acts as a chaperone to AIF protein 
 
 After permeabilization of the OMM, cleaved AIF can be released to the cytosol 
and translocated to the nucleus. However, this translocation seems to be regulated by 
cytoprotective proteins. The first proteins thought to play this role were heat-shock 
proteins (HSPs). This group of proteins is found in most the living organisms, such as, 
bacteria, yeast, humans, and others. They are involved in the folding and unfolding of 
other proteins and their expression increases when cells are exposed to several 
stresses but mostly when cells are exposed to elevated temperatures (Parsell and 
Lindquist, 1993). This family of chaperones recognizes a broad spectrum of unfolded or 
misfolded proteins (Chakrabart et al., 2011). Using a series of biochemical tests, it was 
discovered that, within the family of HSPs proteins, Heat-shock protein 70 (Hsp70p) 
was the only capable of physically interacting with AIF. Hsp70p is involved in the 
inhibition of apoptosis by blocking Apaf-1 and by consequence the formation of the 
apoptosome, (Ravagnan et al., 2001). It also binds to and neutralizes AIF, protecting 
cells against translocation of AIF to the nucleus and by consequence protecting against 
its apoptogenic effects, such as chromatin condensation and fragmentation. This is 
corroborated by several studies, where the authors demonstrate that the interaction 
between AIF and Hsp70p inhibits its translocation to the nucleus both in cultured cells 
and in vivo (Ravagnan et al., 2001 and Ruchalski et al., 2001). However, the precise 
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mechanism of AIF import into the nucleus is not known. Yeast Aif1p shows the same 
localization and exhibits similar death executing pathways as mammalian AIF. 
Therefore, this model system is particularly suitable to investigate the mechanism 
involved in importing AIF to the nucleus. 
 
1.3. Yeast apoptosis 
 
 Over the last decades, Saccharomyces cerevisiae has been a preferred 
research tool in numerous areas of cell biology, due to its easy handling, technical 
tractability, fast growth, small sequenced genome and the fact it is a eukaryote. 
However, it was often questioned whether single-cell organisms need to commit 
suicide or die by apoptosis. In fact, yeast cells tend to form colonies and communities, 
and it is hypothesized that apoptosis may occur in yeast during chronological and 
replicative ageing, leading to removal of virus-infected and damaged cells and 
unsuccessful mating processes from colonies. This altruistic cell death gives younger 
cells nutrients they can metabolize, contributing to the maintenance of the members of 
the community (Büttner et al., 2006) (Figure 6). It has now become clear that apoptosis 
does not occur only in multicellular organisms, but can also be triggered in unicellular 
organisms like yeast. It is believed that several apoptotic pathways are conserved in 
yeast, making this organism attractive to study programmed cell death (Carmona-
Gutierrez et al., 2010).  
 The first observations of yeast apoptosis were made in a mutant strain of S. 
cerevisiae with a mutation in the CDC48 gene, which encodes a protein necessary for 
vesicle trafficking. The authors observed that dying cells of this mutant showed an 
apoptotic phenotype with several characteristics of mammalian apoptosis, such as 
phosphatidylserine exposure to the outer leaflet of the plasma membrane, DNA 
fragmentation and margination, and condensation of chromatin (Madeo et al., 1997). 
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Figure 6 – Representative image of how cell death and ageing occurs in a yeast colony. The amount of 
aged cells located in the center of the colony corresponds to the dead zone. These cells die altruistically to 
give to the younger cells located at the periphery nutrients, allowing the maintenance of the colony 
(adapted from Gourlay et al., 2006). 
 
 Since then, multiple yeast orthologs of mammalian apoptotic proteins have 
been found and characterized. They include AIF, IAP, caspases, AMID, Endo G and 
Omi/HtrA2 (Madeo et al., 2004). In addition, cell death has been associated with 
chronological and replicative ageing and cell cycle arrest (Madeo et al., 2002). 
 Another similarity of yeast apoptosis with mammalian apoptosis is the important 
role of mitochondria in both processes, through ROS production and release of pro-
apoptotic proteins from the mitochondria IMS. Moreover, mitochondrial morphology is 
radically reorganized during apoptosis, from filamentous tubules into small punctate 
spheres. This dynamic nature of mitochondrial morphology is due to two processes, 
fission and fusion, important for maintaining mitochondrial function and repair damaged 
mitochondria. The morphological change of mitochondria seems to be related with cell 
death, as one of the early markers of mammalian apoptosis is fragmentation of tubular 
mitochondria. In yeast, there are three genes involved in mitochondrial fission which 
have been associated with regulation of apoptosis: DNM1, MDV1/NET2 and FIS1. 
Deletion of the first two (DNM1, MDV1/NET2) protects cells from death induced by 
acetic acid or Hydrogen peroxide (H2O2) treatment, whereas deletion of the latter (FIS1) 
leads to an increase in cell death. This observation suggested that Fis1p could have a 
function similar to that of Bcl-2 proteins (Fanjiang et al., 2004). However, it was recently 
found that the sensitivity of fis1 mutants to cell death is due to a secondary mutation 
in the stress-response gene WHI2 (Cheng et al., 2006), which confers a sensitive 
phenotype in response to apoptosis inducers. 
 Like mammals, yeast also has caspase-dependent and caspase-independent 
apoptotic pathways. YCA1, the yeast orthologue of mammalian caspases, is 
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considered a metacaspase and has a central role in yeast apoptosis. It is known that 
yeast cells with a disruption of YCA1 are less susceptible to apoptotic cell death under 
stress conditions like ageing and exposure to oxidative stress, salt, valproic acid, iron 
and other metals. Recently, another caspase-like protease in yeast was found, Eps1p. 
When released from the anaphase inhibitor Pds1p, Eps1p works as a caspase-like 
protease and cleaves Mcd1p. Mcd1p is a yeast homolog of human cohesion Rad21 
that is truncated after apoptotic stimuli and translocates from the nucleus to the 
mitochondria, decreasing the mitochondrial membrane potential and thus promoting 
the release of cytochrome c (Madeo et al., 2009). However, not all yeast apoptotic cell 
death is dependent on YCA1 or on another caspase-like protease.  
 
1.3.1. Yeast apoptotic triggers  
 
 In yeast, apoptosis can be triggered by three different strategies: by 
heterologous expression of pro-apoptotic proteins, by environmental stress or drug-
induced stress, or by yeast endogenous apoptotic inducers. 
 Heterologous expression of proteins consists in expressing one or various 
proteins in an organism that does not possess these proteins in its own genetic 
background. It is described that yeast cells do not possess obvious orthologous of 
proteins from the Bcl-2 family. However, heterologous expression of these human pro-
apoptotic proteins can trigger an active cell death. While some studies showed that 
when Bax or Bak proteins are expressed in yeast, they can trigger cell death with 
apoptotic characteristics, such as release of cytochrome c and generation of ROS, 
others demonstrated that Bax induces a cell death process associated with activation 
of autophagy (Kissova et al., 2007). These facts suggest that these proteins have their 
function conserved in this organism (Eisenberg et al., 2007 and Madeo et al., 2004).  
 It is also known that several exogenous agents such as hyperosmotic stress, 
heavy metals, amiodarone, ethanol, elevated temperatures, oxidative stress, UV 
radiation, various pharmacological agents (such as aspirin), osmotin, viral "killer" 
toxins, HOCl, pheromones and sometimes sugar can efficiently induce apoptosis in 
yeast (Liang et al., 2008; Silva et al., 2005; and Carmona Gutierrez et al., 2010). 
However, the best characterized and the most used exogenous inducers of apoptosis 
in yeast are H2O2 and acetic acid (Madeo et al., 1999 and Ludovico et al., 2001).   
 Finally, several endogenous factors that trigger yeast apoptosis have been 
described, such as defects in cellular processes like chromatid cohesion, N-
glycosylation, mRNA stability (Carmona-Gutierrez et al., 2010). Other examples of 
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endogenous apoptosis triggers are DNA damage resultant from oxygen metabolism 
and ROS generation and failed replication. Chronological and replicative ageing are 
additional examples, and apoptosis also occurs during the development of colonies on 
solid media (Herker et al., 2004 and Vachova and Palkova, 2005). Other endogenous 
triggers are some pro-apoptotic proteins that are released from the mitochondria to the 
cytosol, such as AIF, AIF-homologous mitochondrion-associated inducer of death 
(AMID) and EndoG orthologues, which once in the cytosol are translocated to the 
nucleus.  
 
1.3.2. Yeast orthologue of AIF, Aif1p  
 
 Aif1p, the yeast orthologue of AIF, was first described in 2004 by Wissing et al. 
It was shown that Aif1p, as mammalian AIF, is mitochondrial in normal cells and 
relocalizes to the nucleus in the presence of apoptotic stimuli. It was also found that the 
role of yeast Aif1p is dependent on cyclophilin A and partially on caspase activity. 
Therefore in yeast, in contrast with mammalian cells, Aif1p-mediated apoptosis is not 
completely independent on the yeast metacaspase Yca1p. Moreover, in contrast to 
mammalian AIF, purified Aif1p degrades yeast nuclei and plasmid DNA (Wissing et al., 
2004). 
 AIF1 deletion led to increased survival to treatment with H2O2 and acetate, as 
well as to decreased chronological ageing. Like in mammalian cells, Aif1p also has a 
vital role in respiration via its NADH oxidase domain, and AIF1-deficient S. cerevisiae 
have decreased growth on non-fermentable carbon sources. This redox function is 
important for an effective anti-oxidant defense and oxidative phosphorylation (Madeo et 
al., 2009).  
 
1.3.2.1. Stimuli that regulate Aif1p release 
 
 Ludovico (2002) was the first to observe translocation of Aif1p to the nucleus in 
cells undergoing chronological ageing or treated with camptothecin, an S phase-
specific anticancer drug that inhibits the action of the enzyme DNA topoisomerase-I. 
Then Wissing et al. (2004) also observed translocation of Aif1p to the nucleus, in cells 
treated with H2O2. Since then, few additional studies have addressed this issue and the 
role of Aif1p in yeast apoptosis. Morton et al. described that antimicrobial peptides, the 
dermaseptins obtained from amphibians, are capable of inducing yeast cell death. The 
yeast cell death described by this group is independent of the metacaspase Yca1p but 
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depends on Aif1p for nuclear fragmentation (Morton et al., 2007). Bostrycine is an 
anthracenedione with antimicrobial and phytotoxic activity that belongs to the quinone 
family, which inhibits cell proliferation and induces a decrease in the mitochondrial 
membrane potential, leading to mitochondrial disruption. When yeast cells were treated 
with this compound, cell death with hallmarks of apoptosis was observed. However, 
bostrycin-induced cell death was promoted in yca1Δ. In contrast, this death phenotype 
was partially rescued in aif1Δ cells (Chunlingku et al., 2009). Another substance that 
can induce apoptosis is allicin, an antimicrobial extracted from garlic that is capable of 
inducing apoptosis through its oxidative properties; both Aif1p and Yca1p seem to be 
involved in this process, suggesting that allicin induces apoptosis through an 
alternative mechanism (Gruhlke et al., 2010). 
 So far only H2O2 and chronological ageing have been shown to trigger Aif1p 
release to the cytosol and translocation to the nucleus (Wissing et al., 2004). However, 
there have been no studies addressing the mechanism underlying the import of yeast 
Aif1p into the nucleus, which, like for mammalian AIF, is most likely an active and 
highly regulated process. 
 
1.4. Nucleocytoplasmic trafficking 
 
 The nucleus is a defining characteristic of eukaryotic cells and is physically 
separated from the cytosol by the nuclear envelope (NE), a double membrane 
structure. Most genetic information is confined to the nucleus, where most functions of 
the cell are thus governed. Non-cytosolic proteins synthesized in the cytoplasm have to 
be directed to their specific locations, where they exert their functions. For that they 
contain a signal sequence that will direct them to a specific location. For example, 
proteins containing a nuclear localization sequence (NLS) are imported into the 
nucleus (Macara, 2001).  
 
1.4.1. Nuclear Pore Complex (NPC) 
 
 The NE is crossed by multiple supramolecular structures named nuclear pore 
complexes (NPCs), structures specialized in transport of small molecules, ions and 
macromolecules between the cytoplasm and the nucleus. The number of NPCs in each 
cell is variable and depends on cell size and transcriptional activity, and differs between 
species. Human cells may contain about 5x103 – 5x107 NPCs per nucleus and these 
NPCs have about 60 MDa of molecular weight. The yeast NPC is much smaller than 
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that of higher eukaryotes, with a molecular weight of approximately 44 MDa, and there 
are about 200 NPCs per nucleus (Freitas et al., 2009). 
 NPCs consist of a cylindrical central body sandwiched between the outer and 
inner layers of the NE. Nucleoplasmic and cytoplasmic rings are constituted by eight 
subunits that constitute the central structure. Eight protein filaments rise up from the 
cytoplasmic ring towards the cytoplasm, and the nuclear ring forms eight filaments that 
converge in a structure named nuclear basket, as shown in figure 7.  
 
 
 
 
Figure 7 - Representation of a human nuclear pore complex (NPC) showing its morphology (Bayliss et al., 
2000). 
 
 The central structure of the human NPC has a central channel about 30 nm in 
diameter that allows the transport of ions and proteins with a molecular weight of 20-40 
kDa (Bayliss et al., 2000). Some proteins can be transported into the nucleus by an 
intrinsic ability to directly interact with the NPC, but most are transported through the 
NPC by association with several types of transport receptors. The overall structure of 
the NPC is similar between human and yeast, but yeast NPCs lack the cytoplasmic and 
nuclear rings (Rout et al., 2000). Amazingly, despite their large size, purified yeast 
NPCs contain only about 30 different proteins, named nucleoporins (Nups). Nups can 
be separated into three groups: nucleoporins that span the nuclear membrane; non-
membrane proteins that have multiple repeats of a phenylalamine-glycine (phe-gly) 
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motif, and non-membrane proteins that don’t have the phe-gly motif (Macara et al., 
2001). 
 
1.4.2. Protein transport receptors and transport cycle 
 
 For the majority of macromolecules, transport into the nucleus and through the 
NPCs is an energy-dependent process. This process can be mediated by the major 
class of transport receptors, which includes different soluble proteins (karyopherins or 
Kaps, also named importins, exportins or transportins). They mediate import into or 
export from the nucleus of proteins that cannot be transported by simple diffusion 
through the NPCs, as well as mediate the transport of non-coding RNAs. Karyopherins 
are acidic proteins with a molecular weight of 90 to 145 kDa. About 10 of the 20 
karyopherins identified were demonstrated to participate in the nuclear import of 
proteins in eukaryotes (Tran et al., 2006). Sequence analysis identified 13 predicted 
importin-β proteins in the yeast S. cerevisiae. 
 Most transport receptors of the importin-β family are capable of binding directly 
to cargo and transport it across the NE while others, like importin-β, need an adaptor. 
Importin-β can interact with importin-α and mediate a process of transport into and out 
of the nucleus. Importin-α is a transport adaptor that recognizes and binds to the NLS 
of proteins. The NLS-binding domain is formed by 10 arginine-rich motifs (ARM) in 
tandem, localized on the central region of importin-α. The NLS of the cargoes is 
recognized by importin-α through ARM, and the interaction between the importins is 
mediated by an importin-β binding domain (IBB) that is localized in the N-terminal 
region of importin-α. The cargo/importin-α/importin-β complex is then transported 
through the NPCs. In the nucleus, this complex is dissociated by binding of Ran-GTP 
to importin-β, which displaces the cargo. Importin-α is then transported back to the 
cytosol by the exportin Cse1/CAS (Figure 8) (Cook et al., 2007). However, most 
karyopherins are able to directly interact with their cargo and recognize a variety of 
nuclear localization signals, though most are basic in nature. 
 Another important characteristic of karyopherins is that they can interact with 
Ran GTPase and the phe-gly domains of nucleoporins. Ran GTPase, a monomeric 
protein belonging to the Ras superfamily, can be found in two distinct forms; GTP-
bound and GDP-bound, and these two different forms are distributed asymmetrically in 
the nucleus (more Ran-GTP) and in the cytoplasm (more Ran-GDP). Specific 
regulatory proteins that are localized in the cytoplasm and the nucleus maintain the 
asymmetric distribution of these proteins. Normally, the reaction of hydrolysis of GTP 
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into GDP is slow; however, this reaction can be accelerated by two proteins, Ran-GAP 
and Ran-BP1. On the other hand, the nuclear protein RCC1 promotes the reverse 
reaction. It is the combined action of Ran regulatory proteins that creates and 
maintains the Ran-GTP gradient across the NE, and it is this gradient that establishes 
the directionality of nucleocytoplasmic transport (Freitas et al., 2009). 
 
 
.  
 
Figure 8 - Overview of the transport cycle of the classical nuclear localization signal (NLS) transport with 
the ligation of importin-β and importin-α (Cook et al., 2007). 
 
 Ran-GTP binds to the transport receptors (importin-β family) and also to other 
proteins in solution. Ran-GTP, in the nucleoplasmic side of the NPC, dissociates import 
receptors from their cargo, promoting release of the cargo. In contrast, it promotes the 
formation of export complexes. Ran-GAP and Ran-BP1, located in the cytoplasm, 
promote hydrolysis of Ran-GTP bound to export complexes, releasing the cargo and 
freeing the carrier for another round of transport (Figure 9).  
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Figure 9 - Schematic representation of processes underlying nuclear import and export mediated by β-
karyopherins (Importin-β) (Bayliss et al., 2000). 
 
 Several cycles of export complexes with Ran-GTP would lead to depletion of 
Ran from the nucleus. Ran is small and can therefore diffuse through the NPC, but this 
mechanism is not fast enough for efficient nuclear trafficking (Bayliss et al., 2000). It is 
known that the nuclear import of Ran-GDP is promoted by the nuclear transport factor 
NTF2/p10. After import of Ran-GDP to the nucleus, the protein RCC1 will convert the 
Ran-GPD into Ran-GTP (Figure 10) (Cook et al., 2007, Freitas et al., 2009). The levels 
of Ran-GTP are thus replenished in the nuclear side, allowing for continuous cycles of 
import and export. 
 
 
 
 
Figure 10 - Schematic representation of the Ran cycle (Cook et al., 2007). 
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1.4.3. Regulation of nucleocytoplasmic trafficking 
 
 As mentioned above, the majority of proteins are synthesized in the cytosol and 
then transported to their final localization in order to exert their function. This process is 
often an important regulatory step in cellular pathways. Indeed, there are several 
examples of proteins whose function is regulated by nuclear localization. One example 
is NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells), a 
transcription factor found in almost all types of mammalian cells. It is involved in the 
cellular response to several stimuli, such as several types of stress, cytokines, 
ultraviolet radiation, free radicals and LDL oxidation. This transcription factor is bound 
to an inhibitory protein (IkB) in unstimulated cells and therefore is latent. However, 
upon activation by extracellular agents, IkB is phosphorylated by a protein kinase and 
then ubiquitinated and degraded by the proteasome, allowing NF-kB translocation to 
the nucleus. There, it binds to the kB consensus sequence generally leading to an 
increase in the expression of the target gene (O’Neill et al., 1997). 
 Another example is the yeast transcription factor Yap1p, which regulates 
expression of target genes containing a binding site named Yap1p-response element 
on their promoter. Normally Yap1p is located in the cytosol and is translocated into the 
nucleus under stress conditions. In the nucleus, nuclear export of Yap1p is inhibited, 
which leads to its accumulation in the nucleus and consequently inducing the 
expression of several genes encoding antioxidant proteins. Exposure to H2O2 induces 
the formation of disulfide bonds between the C-terminal cysteine-rich domain (C-CRD) 
and the N-terminal cysteine-rich domain (N-CRD) of Yap1p. The C-CRD possesses a 
NES, which ordinarily leads to export of Yap1p from the nucleus, but it is masked by 
this dually disulfide-bonded structure. Therefore, Yap1p export is inhibited, promoting 
Yap1p nuclear accumulation (Gulshan et al., 2005).  
 Another example of regulated transport is the regulation of protein localization 
by phosphorylation and desphosphorylation of the yeast transcription factor Pho4p. 
Pho4p localization is regulated in response to modifications in the concentration of 
inorganic phosphate in the media. Pho4p is imported into the nucleus through the 
importin-β family member Pse1p/Kap121p. It is known that inhibition of the 
Pho4p/Pse1p interaction is mediated by phosphorylation and that Pho4p translocation 
requires Pse1p. This suggests that this import is regulated by phosphorylation in vivo. 
In yeast cells grown in phosphate-rich medium, Pho4p is phosphorylated by the Pho80-
Pho85 cyclin-CDK complex and import into the nucleus is therefore inhibited. 
Consequently, there is no transcription of phosphate starvation-specific genes. 
However, in yeast grown with limited phosphate, the CDK inhibitor Pho81p inhibits 
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Pho80-Pho85, leading to accumulation of unphosphorylated Pho4p. Unphosphorylated 
Pho4p can then interact with Pse1p/Kap121p, translocate into the nucleus and induce 
transcription of phosphate-responsive genes (Kaffman et al., 1998). 
 
1.4.4. Nuclear import of AIF 
 
 AIF function is regulated at different levels including through its subcellular 
localization. As mentioned above, AIF is transported to the mitochondria due to the N-
terminal MLS. After mitochondrial membrane permeabilization, truncated AIF is 
released into the cytosol and then translocated to the nucleus.  
 The crystal structure of AIF indicates that this protein has to be re-localized to 
the nucleus to exert its apoptotic activity (Ye et al., 2002). To discover which region of 
this gene is responsible for the apoptotic activity of this protein, Gurbuxani and 
colleagues mapped functional regions of AIF by deleting several regions and observing 
the resultant phenotype. The authors determined that the C-terminal domain (beyond 
residue 567) is responsible for AIF-induced chromatin condensation (once AIF is in the 
nucleus). Deletion of the Hsp70p-binding region (residues 150 to 228) leads to a gain 
of function phenotype, i.e., facilitates nuclear translocation in response to an apoptotic 
stimulus. One region of AIF contains a consensus NLS (residues 367 to 459), normally 
involved in protein translocation to the nucleus. However, two NLS domains are 
described for AIF, one more N-terminal (residues 277 to 301) and another closer to the 
C-terminus (residues 445–451) (Susin et al., 1999). In this study, the authors showed 
that the C-terminal NLS is functionally more important for AIF translocation to the 
nucleus than the N-terminal NLS domain. However, deletion of the region containing 
the C-terminal NLS only partially inhibited AIF translocation, which suggests that there 
are other domains involved in AIF import (Gurbuxani et al., 2003). However, the 
mechanism mediating this nuclear translocation of AIF is still unclear. 
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 Apoptosis-inducing factor is a flavoprotein with oxidoreductase activity localized 
in the mitochondrial intermembrane space. Upon apoptosis induction, AIF translocates 
to the nucleus, where it leads to chromatin condensation and DNA degradation. AIF 
has been suggested to control a caspase-independent pathway of apoptosis, important 
for neurodegeneration and normal development. However, it remains unknown how 
AIF translocates to the nucleus. Yeast Aif1p shows the same localization and exhibits 
similar death executing pathways as mammalian AIF, though it mediates a partially 
caspase- dependent pathway (Wissing et al., 2004). Therefore, our aim was to use the 
yeast model system to investigate the mechanism involved in importing Aif1p to the 
nucleus.  
 
 
Aim 1. Determine which soluble import factor is necessary to import Aif1p 
 
 Transform mutants in each of the yeast soluble transport receptors (Kaps) with 
Aif1p-GFP and assess the localization of Aif1p after apoptosis induction by 
fluorescence microscopy. Mutation of the Kap mediating Aif1p import will prevent its 
nuclear accumulation. 
 
 
Aim 2. Map the NLS of Aif1p 
  
 Clone different fragments of Aif1p in frame with GFP and assess their 
localization by fluorescence microscopy. Identify the smallest sequence that is both 
necessary and sufficient for transport into the nucleus. 
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3.1. Plasmids  
 
 All the plasmids and oligonucleotides used in this work are listed in Table I and 
ll, respectively. Plasmids were amplified in the Escherichia coli XL1Blue strain (as 
described below) and purified using a Miniprep kit (GenElute Plasmid Miniprep kit, 
Sigma-Aldrich) according to manufacturer’s instructions. The identity of the plasmids 
was confirmed by digestion with specific restriction enzymes and by PCR.  
 pAIF1WT-GFP, pAIF1ΔMLS-GFP, pAIF1ΔHSP70-GFP, pAIF1ΔNLS-GFP were 
constructed by Gap Repair (Figure 11). Briefly, four fragments of the AIF1 gene (Wild-
type AIF1, AIF1 ΔMLS, AIF1 ΔHSP70, AIF1 ΔNLS) were amplified by Polymerase 
Chain Reaction (PCR) using the plasmid pAIF1 from Euroscarf as a template and 
oligonucleotides forward 1-4, respectively, and the reverse oligonucleotide 5 (Table II). 
Saccharomyces cerevisiae strain DF5a was transformed with pYX242GFP vector 
digested with EcoRI and HindIII and each of the four fragments (Figure 11). Correct 
integration of the AIF1 fragments in pYX242GFP was confirmed by colony PCR using 
oligonucleotides that anneal upstream and downstream of the insertion (6 and 7, 
respectively). After confirmation, the plasmids were purified from yeast cells (described 
below in 3.6), amplified in E. coli and sequenced. 
 
Table I – List of the plasmids used in this work. 
Plasmid Description References/Sources 
pAIF1 AIF1 ORF Euroscarf (Germany) 
pYX242GFP LEU2, AmpR Rosenblum et al., 1998 
pAIF1WT-GFP AIF1 1-1137 cloned in pYX242GFP This study 
pAIF1ΔMLS-GFP AIF1 Δ1-78 cloned in pYX242GFP This study 
pAIF1ΔHSP70-GFP AIF1 Δ1-336 cloned in pYX242GFP This study 
pAIF1ΔNLS-GFP AIF1 Δ1-723 cloned in pYX242GFP This study 
pBAX c-myc Bax c-myc cloned in PCM189, URA3 Priault et al., 1999 
 
Table II – List of the oligonucleotides used in this work. 
Number Name Oligonucleotide sequence (5’ - 3’) 
1 AIF1WT Fw ATCTATAACTACAAAAAACACTATCAGGAATTCGGGCCCATGACA 
2 AIF1ΔMLS Fw 
ATCTATAACTACAAAAAACACTATCAGGAATTCGGGCCCATGAGGG
AACTGGGT 
3 AIF1ΔHSP70 Fw ATCTATAACTACAAAAAACACTATCAGGAATTCGGGCCCATGCCA 
4 AIF1ΔNLS Fw ATCTATAACTACAAAAAACACTATCAGGAATTCGGGCCCATGGGT 
5 AIF1 Rev GACAACAACAGTGAATAATTCTTCACCTTTAGACATCCGGGG 
6 YX Fw ATCTATAACTACAAAAAACACATACAGGAATTCGGGCCCATGACA 
7 GFP Rev AGCGTCGACGTTACCTTATTTGTACAATTCATCCATACCATGGG 
8 YX Fw  CTTTTTAATTCTAAATCAATCTTTTTCAA 
9 GFP Rev AACATCACCATCTAATTCAAC 
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Figure 11 - Schematic representation of the methodology used in the amplification of AIF1 fragments 
(AIF1 ΔMLS, AIF1 ΔHSP70, AIF1 ΔNLS) and construction of plasmids. 
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3.2. Yeast strains and growth conditions 
 
 All S. cerevisiae strains used in this work and respective genotypes are shown 
in Table III. Strains were transformed with the indicated plasmids using the Lithium 
acetate/Single Stranded carrier DNA/Polyethylene Glycol (PEG) method previously 
described in (Gietz and Woods, 2006). Transformants were selected on Synthetic 
Complete (SC) medium [SC containing 0.17% (w/v) Yeast nitrogen base without 
aminoacids and ammonium sulfate, 0.5% (w/v) ammonium sulfate, 0.14% (w/v), drop-
out mixture lacking histidine, leucine, tryptophan and uracil, 0.008% (w/v) Histidine, 
0.04% (w/v) Leucine, 0.008% (w/v) Tryptophan and 0.008% (w/v) Uracil] lacking the 
appropriate aminoacids plus 2% (w/v) of carbon source and 2% agar. Yeast strains 
were maintained on solid YPD or SC medium (lacking the appropriate amminoacids), 
grown at 30°C for 48 h, stored at 4°C, and refreshed every 2 weeks. Yeast cultures 
were grown aerobically in SC medium with 2% Glucose or Galactose as a carbon 
source. Strains transformed with plasmids were grown in the same medium lacking the 
appropriate amino acids. Cells were incubated at 30°C with orbital shaking (200 rpm) 
and a liquid/air ratio of 1:5. 
 
3.3. Hydrogen peroxide and acetic acid treatment 
 
 Cells were grown overnight until exponential phase (OD600  = 0.5-0.6) on SC 
Glu, collected by centrifugation and resuspended in new medium (medium with pH 3 in 
the case of acetic acid treatment) to a final concentration of 107 cells/mL 
(approximately OD600 = 0.2) and incubated with H2O2 (1 mM, 2 mM and 3 mM), or 
acetic acid (140 mM, 160 mM, 180 mM) for up to 360 min at 30°C. At specific time 
points, serial dilutions (1:10) were spotted onto YPD plates and colony growth was 
scored after 2 days of incubation at 30°C. Viability was determined in relation to time 0 
(100%). In parallel, 500 µL of cells were harvested and processed for fluorescence 
microscopy. 
 
3.4. Heterologous expression of Bax c-myc 
 
 Strains harboring the plasmid pBAX c-myc were grown overnight in SC Glucose 
lacking uracil and supplemented with doxycycline (10 µg/ml) to repress Bax c-myc 
expression. Cells were centrifuged, washed three times with sterilized water, 
ressuspended in the same medium without doxycycline (to induce Bax c-myc 
expression) or with doxycycline (as a negative control). At specific time points, serial 
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dilutions (1:10) were spotted onto YPD plates and colony growth was scored after 2 
days of incubation at 30°C. Viability was determined in relation to time 0 (100%). In 
parallel, 500 µL of cells were harvested and processed for fluorescence microscopy. 
 
Table III – List of S. cerevisiae strains used in this work. 
Strain Genotype Reference/Source 
DF5a 
Mat a; ura3-52, leu2-3, 112 lys2-801, trp1-1, 
his3Δ200 
Finley et al., 1987 
BY4741 Mat a; his3Δ 1, leu2Δ 0, met15Δ 0, ura3Δ 0 Euroscarf (Germany) 
BY4742 Mat α; leu2, lys2, ura3, his3 Euroscarf (Germany) 
W303a Mat a; ade2; ura3; his3; trp1; leu2 Costa V., IBMC 
ssa1Δ BY4741 YAL005C :: KanMX4 Euroscarf (Germany) 
DF5a pYX242GFP DF5a harboring pYX242GFP This study 
DF5a pAIF1WT-GFP DF5a harboring pAIF1WT-GFP This study 
DF5a pAIF1ΔMLS-GFP DF5a harboring pAIF1ΔMLS-GFP This study 
DF5a pAIF1ΔHSP70-GFP DF5a harboring pAIF1ΔHSP70-GFP This study 
DF5a pAIF1ΔNLS-GFP DF5a harboring pAIF1ΔNLS-GFP This study 
W303 pAIF1WT-GFP W303 harboring pAIF1WT-GFP This study 
W303 pAIF1ΔMLS-GFP W303 harboring pAIF1ΔMLS-GFP This study 
W303 pAIF1ΔHSP70-GFP W303 harboring pAIF1ΔHSP70-GFP This study 
W303 pAIF1ΔNLS-GFP W303 harboring pAIF1ΔNLS-GFP This study 
W303 pAIF1WT-GFP pBAX 
c-myc 
W303 harboring pAIF1WT-GFP and pBAX c-
myc 
This study 
BY4741 pAIF1WT-GFP BY4741 harboring pAIF1WT-GFP This study 
BY4741 pAIF1ΔMLS-GFP BY4741 harboring pAIF1ΔMLS-GFP This study 
BY4741 pAIF1ΔNLS-GFP BY4741 harboring pAIF1ΔNLS-GFP This study 
BY4741 pAIF1WT-GFP 
pBAX c-myc 
BY4741 harboring pAIF1WT-GFP and pBAX 
c-myc 
This study 
BY4741 pAIF1ΔMLS-GFP 
pBAX c-myc 
BY4741 harboring pAIF1ΔMLS-GFP and  
pBAX c-myc 
This study 
ssa1Δ pAIF1WT-GFP ssa1Δ harboring pAIF1WT-GFP This study 
ssa1Δ pAIF1ΔMLS-GFP ssa1Δ harboring pAIF1ΔMLS This study 
ssa1Δ pAIF1WT-GFP pBAX 
c-myc 
ssa1Δ harboring pAIF1WT-GFP and pBAX 
c-myc 
This study 
ssa1Δ pAIF1ΔMLS-GFP 
pBAX c-myc 
ssa1Δ harboring pAIF1ΔMLS-GFP and 
pBAX c-myc 
This study 
 
 
3.5. Transformation of bacterial cells 
 
 Super Optimal Broth medium (250 ml) [SOB; 2% (w/v) Tryptone peptone; 0.5% 
(w/v) Yeast extract; 2.5 mM KCl, 10 mM NaCl; 10 mM MgSO4, 10 mM MgCl2] was 
inoculated with 2 colonies of XL1Blue E. coli strain and grown at 18°C, 200 rpm with a 
ratio of flask liquid/air of 1:5 until OD600 = 0.6, about 4-5 days. Then the culture was 
placed on ice for 10 min and the cells pelleted for 10 min at 2500g, at 4°C. The pellet 
was suspended in 80 mL ice-cold TB buffer [10 mM Pipes; 15 mM CaCl2; 250 mM KCl; 
55 mM MnCl2] and left on the ice for 10 min. Cells were centrifuged for 10 min at 2500 
g and gently suspended in 20 mL ice-cold TB buffer. DMSO was added to a final 
concentration of 7% and cells incubated on ice for 10 min. Finally, competent cells 
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were aliquoted, frozen with liquid nitrogen and stored at -80°C. E. coli transformation 
was performed by a standard protocol for chemically competent cells and 
transformants selected on Luria Bertani medium [LB; 1% (w/v) Tryptone, 0.5% (w/v) 
Yeast extract, 1% (w/v) NaCl and 2% (w/v) Agar] with 100 μg/mL of Ampicillin.  
 
3.6. Purification of Yeast DNA 
 
 Plasmid DNA from yeast cells was purified using the GenElute Plasmid 
Miniprep kit (Sigma-Aldrich) according to manufacturer’s instructions, with 
modifications. Cells from a 10 mL overnight culture were centrifuged and the pellet 
resuspended in 200 µL of Resuspension solution. About 200 µL of glass beads and 10 
µL of lyticase were added to the cells and the tubes incubated for 10-20 min at 37°C. 
Next, tubes were vortexed for 15 min. Cells were lysed by adding 200 µL of Lysis 
solution and gentle inversions of the tubes. 350 µL of Neutralization solution was 
added and the tubes inverted 5-6 times, and the lysate spun at 15000 rpm for 10 min. 
The columns from the kit were washed with 500 µL of Column Preparation solution, 
and the supernatant from the neutralization step was loaded into the columns after 
centrifugation at 15000 rpm for 1 min, columns were washed with 500 µL of Wash 
Optional solution, then with 750 µL of Wash solution and dried. The columns were 
changed to new tubes, and DNA eluted with 50 µL of Elution buffer. 
 
3.7. Fluorescence Microscopy 
 
 Samples (200 µL) were harvested and centrifuged for 2 min at 10000 rpm, and 
the pellet was resuspended in 100 µL of Phosphate-Buffered Saline [PBS; 80 mM 
Na2HPO4, 20 mM NaH2PO4 and 100 mM NaCl], fixed in 100% (v/v) ethanol and 4 µL of 
DAPI (2 µg/mL) added. After 5 min of incubation, cells were washed twice with PBS 
and resuspended in 10 µL of PBS. Cells were visualized in a Leica Microsystems DM-
5000B epifluorescence microscope using appropriate filter settings with a 100x oil 
immersion objective. Images were acquired with a Leica DCF350FX digital camera and 
processed with LAS AF Leica Microsystems software. 
 
3.8. Subcellular fractionation 
3.8.1. Preparation of spheroplasts 
 
 Cells were grown in 2.4 L of SC medium without appropriate aminoacids and 
using Galactose as the carbon source, to obtain more mitochondrial mass. For acetic 
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acid treatment, cells were grown until late exponential phase (OD600 = 1) and the 
culture divided in two: one culture, without treatment, was used as a negative control 
and the other was treated with 120 mM of acetic acid (pH 3,0) for 120 min. For Bax c-
myc expression, cells were treated as described above, in the presence and absence 
of doxyclyclin. Cells were collected and incubated in Pre-incubation buffer [0.5 M β-
mercaptoethanol, 0.1 M Tris, pH 9.3] for 15 min at 30°C and washed 2 times with 
Tris/KCl buffer [10 mM Tris, 0,5 M KCl, pH 7]. Spheroplasts were obtained by 
incubation in Digestion buffer [1.35 M Sorbitol, 10 mM Citric acid, 30 mM Na2PO4, 1 
mM EDTA, pH 5.8] containing 10 mg or 50 mg of zymoliase /1 O.D for untreated and 
treated cells. Digestion of cell wall was performed during 30 and 50 min for untreated 
and treated cells, respectively. 
 
3.8.2. Mitochondrial and cytosolic fraction preparation 
 
 Spheroplasts were washed with  Washing buffer [0.750 M Sorbitol, 0.4 M 
Mannitol, 10 mM Tris Maleate, pH 6.8] and disrupted by osmotic shock in 
Homogenization buffer [0.6 M Mannitol, 10 mM Tris Maleate, pH 6.8] and mild 
homogenization in a hand-potter, to preserve the outer mitochondrial membrane. The 
homogenate was centrifuged at 2500 rpm to remove cell debris and nuclei, and the 
supernatant centrifuged at 15000 rpm for 15 min. The pellet corresponds to the 
mitochondrial fraction and the supernatant to the cytosolic fraction. Mitochondria were 
then resuspended in Recuperation buffer [0.6 M Mannitol, 2 mM EDTA, 10 mM Tris 
Maleate, pH 6.8].  
 
3.8.3. Nuclear fraction preparation 
3.8.3.1. Protocol I 
 
 Crude nuclei resulting from the 2500 rpm centrifugation were washed 3 times 
with Recuperation buffer (3000 g for 5 min) and the final washed pellet resuspended in 
Recuperation buffer and loaded onto a Ficoll 400 step gradient in Ultra-Clear tubes (30, 
40 and 50% (w/v)). The gradient was centrifuged at 18000 rpm for 60 min at 2°C. The 
nuclei band in the 40% layer was collected. Tubes containing the nuclear extract were 
stored at -80°C. 
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3.8.3.2. Protocol II 
 
 Spheroplasts were resuspended in half volume of Nuclei buffer [1 M Sorbitol, 20 
mM PIPES pH 6.3, 0.5 mM CaCl2, 1 mM DTT, 0.1 M EDTA, 1 M PMSF] and added 
dropwise to an erlenmeyer containing Ficoll buffer [18% (w/v) Ficoll 400, 20 mM PIPES 
pH 6.3, 0.5 mM CaCl2, 1 mM DTT, 0.1 M EDTA, 1 M PMSF] with continuous agitation, 
in a ice-cold bath to prevent protease activity. The Ficoll suspension was centrifuged at 
5000 rpm for 5 min at 4°C, and this step was repeated until the supernatant become 
clear. The supernatant was then transferred to new tubes and the tubes centrifuged at 
13000 rpm for 20 min at 4°C. The pellet was resuspended in 5-10 volumes of Nuclei 
buffer and the suspension centrifuged again at 9000 rpm for 10 min at 4°C. The final 
pellet (nuclear fraction) was resuspended in Storage buffer [20 mM Tris-HCl pH 7.5, 
0.1 mM EDTA, 100 mM KCl, 10% (v/v) Glycerol] and stored at -80°C. 
 
3.8.3.3. Protocol III 
 
 The third protocol used was based on protocol II, but only serial centrifugations 
were performed. The protocol started with two washes at 500 rpm of the crude nuclei 
resultant from the 2500 rpm centrifugation, followed by centrifugations at 1000, 2000, 
6000, 9000 and 13000 rpm of the supernatants. All centrifugations were performed 
during 10 min and all the washes and resuspensions were made with recuperation 
buffer. Samples of the sedimented pellets in each centrifugation were collected to 
determine the sedimentation pattern of the different organelles.  
 
3.8.4. SDS gel electrophoresis/Westernblot 
 
 Protein concentration of the fractions was estimated through the Bradford 
method using BSA as standard (Bradford, 1976). Proteins (50 µg) of the subcellular 
fractions were separated electrophoretically on a 15% SDS polyacrylamide gel at 20 
mA and transferred to a Hybond-P Polyvinylidene Difluoride Membrane (PVDF) 
(Hybond-ECL, GE Healthcare) at 60 mA for 1 h and 30 min. Membranes were blocked 
for 1 h in PBS-T [PBS with 0.05% (v/v) Tween-20] containing 5% (w/v) non-fat dry milk, 
washed in PBS-T and then cut into strips and incubated with the primary antibodies; 
mouse monoclonal anti-yeast phosphoglycerate kinase (PGK1) antibody (1:5000, 
Molecular Probes), mouse monoclonal anti-yeast porin (POR1) antibody (1:5000, 
Molecular Probes), rabbit polyclonal anti-yeast cytochrome c (CYC1) antibody (1:1000, 
custom-made by Millegen), mouse monoclonal anti-green fluorescent protein (GFP) 
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antibody (1:3000; Roche Applied Science), rabbit polyclonal anti-histone H4 (H4B) 
antibody (1:2000, abcam), rabbit polyclonal anti-human Bax (BAX) antibody (1:10000, 
Sigma). Then membranes were incubated with secondary antibodies against mouse or 
rabbit IgG-peroxidase (1:10000; Sigma Aldrich). Pgk1p and Por1p were used as 
controls for cytosolic and mitochondrial fractions, respectively. Immunodetection of 
bands was revealed by chemiluminescence (Immobilon, Millipore). 
 
3.9. Immunoprecipitation 
 
 Immunoprecipitation was performed using protein G-coupled Dynabeads 
(Invitrogen). Briefly, cytosol was prepared as described above (See 3.8.2), 
supplemented with a mixture of protease inhibitors (0.4 μL/mL Aprotinin, 1 μg/mL 
Leupeptin, 1 μg/mL Pepstatin, 1 mM Phenylmethylsulfonyl fluoride) and with 100 mM 
NaCl and 0.01% NP-40. 1, 2 or 5 μg of monoclonal anti-GFP antibody (Roche Applied 
Science) were added and the lysate was incubated overnight at 4°C with agitation. 
Protein G-coupled Dynabeads (30 µL) were then added and incubated for 6 h at 4°C 
with agitation. Beads were washed 6 times for 2 min with IP buffer [50 mM Tris-HCl, pH 
7.5; 100 mM NaCl; 2 mM EDTA, 0.01% (v/v) NP-40] and bound proteins eluted with 
Laemmli sample buffer for 5 min at 95°C. The sample buffer was collected to new 
tubes. 
 
3.9.1. SDS gel electrophoresis/Western Blot/ Silver Staining of 
immunoprecipitated proteins 
 
 Immunoprecipitated samples were loaded in duplicate onto a 4-20% Mini-
PROTEAN TGX Precast Gel (BioRad) to guarantee a good separation of proteins. One 
half of the gel was transferred to PVDF as described above and Aif1p-GFP detected 
using mouse monoclonal anti-green fluorescent protein (GFP) antibody as the primary 
antibody (1:3000; Roche Applied Science). 
 The other half of the gel was stained by silver staining. The gel was fixed by 
washing at least twice with Fixing Solution [30% (v/v) Ethanol, 10% (v/v) Acetic Acid] 
for 30 min. After fixing, the gel was washed with Washing Solution [30% (v/v) Ethanol] 
for 10 min and with deionized water for 10 min. The gel was then soaked with 
Sensitizing Solution [0.02% (w/v) Sodium Thiosulfate] and carefully agitated for 1 min 
and rinsed three times with deionized water for 30 sec. The gel was then incubated 
with gentle agitation with freshly made Staining Solution [0.15% (w/v) Silver Nitrate] for 
at least 30 min, washed 3 times with deionized water and transferred to Developing 
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Solution [0.05% (v/v) Formaldehyde, 3% (w/v) Sodium carbonate]. When an adequate 
degree of staining was achieved, gels were transferred to Stop Solution [5% (v/v) 
Acetic acid] for 1 min and then placed in deionized water. 
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4.1. Construction of pAIF1WT-GFP plasmid and localization Aif1p  
 
 Aif1p is synthesized in the cytosol and imported into mitochondria, where it 
acquires its mature form. In response to certain stimuli, Aif1p is released to the cytosol 
and then translocated into the nucleus, where it promotes chromatin condensation and 
DNA fragmentation (Norberg et al., 2010). However, the mechanism involved in the 
mobilization of Aif1p between these cellular compartments is not completely 
understood. Our goal was therefore to determine which yeast cytosolic factors are 
required for this nuclear relocalization. First, we aimed to determine which apoptotic 
stimuli triggered this relocalization more efficiently. In order to assess the localization of 
Aif1p, we constructed a plasmid expressing Aif1p in frame with the green fluorescent 
protein (GFP) by gap repair (pAIF1WT-GFP). We then assessed the localization of 
Aif1p-GFP in living cells by fluorescence microscopy (Figure 12). Aif1p-GFP clearly 
localized to the tubular mitochondria network. 
 
 
 
 
Figure 12 – The construction of the plasmid was achieved in the DF5a strain through Gap Repair. AIF1 
was amplified by PCR using as template the pAIF1 from Euroscarf and oligonucleotides 1 and 5 (see 
Table 2). The vector used was pYX242GFP digested with EcoRI and HindIII.PCR confirmation gel of AIF1 
amplification (A) Colony PCR was performed in four candidates using oligonucleotides 5 and 6 to confirm 
the correct insertion of AIF1 into the plasmid (see Table 2) (B). Localization of Aif1p-GFP in the W303 
strain by fluorescence microscopy (C). 
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 It has been described that yeast Aif1p is translocated from the mitochondria to 
the nucleus in response to several stimuli, including exogenous stimuli such as 
chemical stresses (H2O2 or acetic acid), or endogenous stimuli triggered by 
chronological ageing (Gutierrez et al., 2010). Therefore, cells expressing pAIF1WT-
GFP plasmid were exposed to these different apoptosis-inducing conditions. 
Heterologous expression of human pro-apoptotic proteins, such as the pro-apoptotic 
member of the Bcl-2 family Bax, triggers permeabilization of the outer mitochondrial 
membrane (MOMP) and the subsequent release of cytochrome c. Therefore, we also 
addressed whether under this latter condition of MOMP induction, Aif1p is also 
released and translocated to the nucleus. 
 
4.2. Acetic acid treatment and chronological ageing 
 
 Exposure of S. cerevisiae to acetic acid at pH 3 leads to cell death with features 
of mammalian apoptosis, namely exposure of phosphatidylserine, DNA strand breaks 
and chromatin condensation (Ludovico et al., 2001). Moreover, cell death induced by 
acetic acid is associated with the mitochondrial pathway and results in cytochrome c 
release, ROS production and other mitochondrial dysfunctions (Ludovico et al., 2002). 
The length of time that a yeast cell can survive in a non-dividing state is called yeast 
chronological lifespan (Fabrizio and Longo, 2003). Chronological ageing has been 
described as a physiological trigger for apoptosis in yeast (Herker et al., 2004; Fabrizio 
and Longo, 2003). Consistently, Wissing et al. observed nuclear localization of Aif1p in 
chronologically aged cells.  
 We first attempted to observe Aif1p translocation to the nucleus using these two 
stimuli to induce apoptosis. Acetic acid treatment was performed as previously 
described. Cells expressing pAIF1WT-GFP were treated with 140 mM, 160 mM, 180 
mM of acetic acid for up to 360 min or grown for 3-4 days for chronological ageing 
studies, as described by Wissing et al. (2004) and cells were observed by fluorescence 
microscopy. However, we could observe that there was a complete loss of 
fluorescence in cells after acetic acid treatment and chronological ageing, in 
comparison with cells from T0 (data not shown). This may be due to the intracellular 
acidification of cells, which occurs in both cases (Sokolov et al., 2006; Fabrizio et al., 
2004). As accumulation of Aif1p-GFP in the nucleus had been previously observed in 
cells undergoing acetic acid-induced cell death and in aged cells (Wissing et a.l, 2004), 
we hypothesize that the GFP variant used in that study might have been less sensitive 
to pH changes. 
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4.3. Hydrogen peroxide treatment 
 
 Hydrogen peroxide (H2O2) is a reactive oxygen species (ROS) described as an 
apoptotic stimulus at low doses (Madeo et al., 1999). Wissing et al. (2004) described 
that Aif1p-GFP translocates from the mitochondria to the nucleus when cells are 
exposed to H2O2. We therefore next attempted to observe Aif1p translocation to the 
nucleus using H2O2 as an apoptotic stimulus. W303 cells expressing pAIF1WT-GFP 
were grown and treated with 1 mM and 3 mM of H2O2 for up to 360 min, stained with 
DAPI for nuclear staining, and visualized by fluorescence microscopy. Cell viability was 
determined in parallel to confirm if cell death was occurring (Figure 13). 
 
 
 
 
 
Figure 13 – Aif1p-GFP localization in W303 pAIF1WT-GFP cells after treatment with 1 mM and 3 mM of 
H2O2 during 120 (T120), 240 (T240), and 360 min (T360) and the correspondent dropout tests performed 
in YPD plates incubated for 2 days at 30 °C to evaluate cell death. 
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 Exposure to H2O2 resulted in dose-dependent cell death. However, even after 
360 minutes of incubation with different concentrations of H2O2, Aif1p-GFP still did not 
re-localize to the nucleus. It is likely that Aif1p-GFP was not released from 
mitochondria under these conditions, and by consequence not translocated to the 
nucleus. As the mode of H2O2-induced cell death depends greatly on its concentration 
and on growth conditions of the culture, we decided to seek a different stimulus to 
induce mitochondrial outer membrane permeabilization.  
 
4.4. Heterologous expression of Bax c-myc protein 
 
 Bax, a protein from the Bcl-2 family, is the best-studied member of this group 
and has important functions in mitochondrial morphogenesis and cell death (Karbowski 
et al., 2006). Over-expression of Bax in yeast leads to morphological features similar to 
mammalian apoptosis namely plasma membrane blebbing, DNA fragmentation and 
others (Ligr et al., 1998). In yeast, several studies highlighted the role of mitochondria 
in Bax-induced cell death, though as referred in the introduction there is some 
controversy concerning the type of cell death induced by Bax protein. However, it is 
well established that a c-myc tagged version of human Bax triggers mitochondrial outer 
membrane permeabilization and release of cytochrome c from the mitochondria to the 
cytosol. However, is referred before t is not known if it also induces the release of 
Aif1p. The W303 strain expressing pAIF1WT-GFP was therefore transformed with a 
plasmid expressing Bax c-myc, under the control of a tetracyclin-regulatable promoter. 
Expression of Bax- c-myc was inhibited in negative control cells by addition of 1 µg/ml 
of doxycyclin, an antibiotic member of the tetracycline antibiotics group that represses 
the promoter. Cells were therefore grown in the presence or absence of doxycyclin to 
repress or induce expression of Bax (protocol described in 3.5) (Priault et al., 1999). 
Nuclei were then stained with DAPI to observe if Aif1p-GFP translocates into the 
nucleus in response to Bax c-myc expression (Figure 14). 
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Figure 14 – Aif1p localization in W303 cells expressing pAIF1WT-GFP pBAX c-myc. The control 
corresponds to cells that contain doxycycline in the medium to repress pBax c-myc promoter and by 
consequence repress Bax expression. 
 
 Figure 14 shows that, as expected, Aif1p-GFP does not localize to the nucleus 
in control cells. However, we could also not observe accumulation of Aif1p-GFP in the 
nucleus even after expressing Bax c-myc.  
 
4.5. Aif1p translocation to the nucleus and cytochrome c release 
 
 The mitochondrion is considered the guardion of several pro-apoptotic proteins, 
such as Aif1p and cytochrome c (cyt c). Mitochondria outer membrane permeabilization 
(MOMP) occurs in the early stages of apoptosis and enables the release of pro-
apoptotic proteins to the cytosol (Shimizu et al., 2001). MOMP can be triggered by 
several apoptotic stimuli such as acetic acid, heterologous expression of Bax and 
others.  
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 We could not observe the release of Aif1p-GFP to the cytosol or its 
accumulation in the nucleus in the assays described above. Therefore we presumed 
that either MOMP was not occurring under our experimental conditions, or that the 
amount of Aif1p-GFP re-localized was much smaller than that in the mitochondria, 
resulting from Aif1p-GFP overexpression. In the latter case, the strong fluorescence 
signal from mitochondrial Aif1p-GFP could hinder detection of cytosolic and nuclear 
protein. We therefore decided to detect MOMP and the re-localization of Aif1p-GFP by 
performing sub-cellular fractionation by differential centrifugation, to obtain the 
mitochondrial, cytosolic and nuclear fractions using two apoptotic stimuli, acetic acid 
and heterologous expression of Bax c-myc protein. Aif1p-GFP was then detected by 
Western Blot using an anti-GFP antibody. 
 The strain W303 pAIF1WT-GFP was treated with acetic acid as described 
above in 3.3. Mitochondrial and cytosolic fractions were prepared as described in 3.8.2. 
The protocol used to obtain the nuclear fraction was the ficoll gradient protocol 
(protocol l) described above in 3.8.3.1 (Figure 15). 
 
 
 
 
Figure 15 – Western blot of subcellular fractions of S. cerevisiae before (-) and after (+) 120 min treatment 
with 120 mM of acetic acid for the detection of cytochrome c and Aif1p cellular localization. The nuclear 
faction was obtained using protocol I. Loading controls used were cytosolic phosphoglycerate kinase 
(Pgk1p) for the cytosolic fraction, mitochondrial porin (Por1p) for the mitochondrial fraction, and histone H4 
(H4B) for the nuclear fraction. 
  
 Although we obtained a fraction enriched in nuclei, as assessed by the 
enrichment in histone H4B, the protocol used was not efficient. The nuclei fraction 
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obtained in the 40% ficoll layer did not correspond to pure nuclei, as described by 
Vongsamphanh et al., 2001. This fraction was contaminated with mitochondria, as we 
detected a significant amount of Por1p (mitochondrial). Although Aif1p-GFP seemed 
depleted from the mitochondria, it did not accumulate in the cytosol, and its seeming 
accumulation in the nucleus is probably due to the higher amount of mitochondria in 
this fraction (as it had a high amount of Por1p). We could in contrast detect 
accumulation of cyt c in the cytosol of acetic acid-treated cells, indicative of partial 
MOMP. 
 
 We therefore repeated this experiment using a new approach to obtain pure 
nuclei, the protocol II described in 3.8.3.2 (Figure 16).  
 
 
 
 
Figure 16 - Western blot of subcellular fractions.of S. cerevisiae before (-) and after (+) 120 min treatment 
with 120 mM of acetic acid for the detection of Aif1p cellular localization. The nuclear faction was obtained 
using protocol II. Loading controls used  were cytosolic phosphoglycerate kinase (Pgk1p) for the cytosolic 
fraction, mitochondrial porin (Por1p)  for the mitochondrial fraction, and histone H4 (H4B) for the nuclear 
fraction. 
 
 
 The results obtained with this new approach were basically the same as in the 
first attempt. We also detected Por1p in the nuclear fractions, which indicates 
contamination with mitochondria, and detected H4B not only in the nuclear fraction 
suggesting that probably the mitochondrial fractions were also contaminated with 
nuclei. We also did not observe Aif1p release to the cytosol or translocation to the 
nucleus. We therefore attempted to optimize the yeast nuclei isolation protocol using 
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differential centrifugations (protocol III described in 3.8.3.3) (Figure 17). We observed 
that the majority of nuclei sedimented at 1000 rpm, and most mitochondria sedimented 
at 3000 and 6000 rpm. However, there was a high amount of Por1p in the 1000 rpm 
fraction, and thus this fraction was still highly contaminated with mitochondria. We 
could not therefore satisfactorily separate these two organelles. 
 
 
 
 
Figure 17 - Western blot of different samples resulted from differential centrifugations (Protocol III). 
Cytosolic phosphoglycerate kinase (Pgk1p) level was used as control for cytosol for mitochondria the 
control used was the mitochondrial porin (Por1p) and for the nuclei the histone H4 was used. SN 
represents the Supernatant. 
 
 Since we weren’t able to observe Aif1p-GFP release from mitochondria using 
acetic acid as a MOMP inducer, our next strategy was to perform sub-cellular 
fractionation in cells expressing Bax protein and evaluate the release of cyt c and 
Aif1p. For this purpose, W303 pAIF1WT-GFP pBAX c-myc cells were grown until late 
exponential phase. Sub-cellular fractionation was performed to obtain purified 
mitochondria and cytosol (Figure 18). 
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Figure 18 - Western blot of subcellular fractions of S. cerevisiae without (-) and with (+) heterologous 
expression of Bax c-myc protein for 14 h, for the detection of cytochrome c and Aif1p cellular localization. 
Cytosolic phosphoglycerate kinase (Pgk1p) levels were used as the loading control for the cytosolic 
fraction; mitochondrial porin (Por1p) levels were used as the loading control for the mitochondrial fraction. 
To confirm heterologous expression of Bax protein, Bax detection was performed with an anti-Bax 
antibody. 
 
 Heterologous expression of Bax protein in yeast leads to cyt c release from the 
mitochondria to the cytosol (Manon et al., 1997). We therefore sought to determine if 
Aif1p was also released from mitochondria when cells are expressing the pro-apoptotic 
protein Bax. Western blot analysis showed that heterologous expression of Bax protein 
induced cyt c release in yeast under our experimental conditions, as already described. 
However, we detected only a minor increase in cytosolic Aif1p-GFP, along with 
cytochrome c release, and only a minor decrease in mitochondrial Aif1p-GFP. These 
results indicate Bax c-myc did induce MOMP and cytochrome c release, and likely a 
small amount of Aifp-GFP release, which is consistent with the results we obtained by 
fluorescence microscopy. The small differences observed would nonetheless not be 
sufficient to use this method to uncover proteins necessary for Aif1p to accumulate in 
the nucleus. 
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4.6. Map the NLS of Aif1p 
 
 The majority of proteins contain localization signals responsible for directing the 
proteins to a specific location, for example to mitochondria (MLS) or to nuclei (NLS). 
Since we could not observe Aif1p translocation to the cytosol and then to the nucleus, 
we decided to pursue another strategy to uncover the soluble factor(s) responsible for 
transporting Aif1p to the nucleus. For this purpose, we aimed to identify the Aif1p NLS, 
as expressing an Aif1p domain targeted to the nucleus would greatly facilitate this 
study. 
 
4.6.1. Construction of AIF1 fragments and localization of Aif1p 
 
 Three different fragments of AIF1 were amplified by PCR and then inserted into 
the pYX242GFP plasmid by gap repair. Fragment 1 (AIF1 ∆MLS) starts at nucleotide 
78, thus lacking the sequence encoding the MLS. Fragment 2 (AIF1 ∆HSP70) starts at 
nucleotide 336, lacking the MLS and the sequence homologous to the Hsp70p binding 
site of human AIF, but containing the sequence homologous to the presumed NLS of 
human AIF. Fragment 3 (AIF1 ∆NLS) starts at nucleotide 723, resulting in elimination of 
all the aforementioned domains (Figure 19A). Correct insertion of the fragments into 
the plasmid was confirmed by colony PCR (Figure 19B) and the localization of Aif1p-
GFP in the cells determined by fluorescence microscopy (Figure 19C).  
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Figure 19 – Confirmation gel of AIF1 fragments obtained by PCR using as template the pAIF1 from 
Euroscarf and oligonucleotides 2, 3, 4 and 5 (see Table II) (A) Confirmation of the correct insertion of AIF1 
fragments in the pYX242GFP plasmid performed in four candidates by colony PCR using oligonucleotides 
5 and 6 (B); Aif1p-GFP localization in W303 cells expressing pAIF1ΔMLS-GFP, pAIF1ΔHSP70-GFP and 
pAIF1ΔNLS-GFP by fluorescence microscopy (C).  
 
 
 As expected, and in contrast to Aif1p-GFP, Aif1p ΔMLS-GFP seems to have a 
cytosolic localization, showing that deletion of the MLS prevents translocation of Aif1p 
to the mitochondrion after synthesis in the cytosol. On the other hand, Aif1p isoforms 
without the MLS and the Hsp70p binding site, and without all three domains (MLS, 
Hsp70p binding site and the NLS), showed a punctate localization pattern reminiscent 
of aggregates, which did not co-localize with the nuclei (Figure 20). 
 
 
 
 
 
 
(b) 
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Figure 20 – Co-localization of the three Aif1p fragments with the nucleus. Representative images of W303 
pAIF1ΔMLS-GFP, W303 pAIF1ΔHSP70-GFP, W303 pAIF1ΔNLS-GFP cells by fluorescence microscopy, 
respectively. Cells were incubated with DAPI for nucleus staining.  
  
 Hsp70p interacts with AIF, and may stabilize it in the cytosol (Gurbaxini et al., 
2003). Deletion of the yeast Aif1p sequence homologous to the Hsp70p binding 
domain of AIF1 resulted in an aberrant localization and possibly in a misfolded protein. 
If this was due to deletion of a true Hsp70p binding domain in Aif1p, absence of yeast 
Hsp70p (Ssa1p) would result in the same phenotype. We therefore transformed an 
ssa1Δ strain and corresponding wild-type with the pAIF1ΔMLS-GFP (Figure 21).  
 
 
 
 
Figure 21 – Observation of aggregates formation in ssa1Δ cells expressing pAIF1ΔMLS-GFP in contrast 
with control cells (BY4741 strain) expressing the same plasmid. 
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 As shown in Figure 21, Aif1p ΔMLS-GFP has a diffuse localization. In contrast, 
in ssa1Δ cells, Aif1p ΔMLS-GFP has localization reminiscent of that of Aifp ΔHSP70-
GFP. These results indicate yeast Aif1p may indeed also contain an Hsp70p binding 
domain, and likely interact with the yeast Hsp70p. 
 
4.7. Protein-protein interactions of Aif1p 
 
 We next sough to determine whether Aif1p interacts with Hsp70p in the cytosol, 
as well as uncover which proteins it may interact with that regulate its localization and 
possibly its function. Extracts from wild-type and ssa1Δ cells expressing pAIF1ΔMLS-
GFP were incubated overnight with three different concentrations of antibody against 
GFP (1, 2 and 5 µg) to immunoprecipitate proteins interacting with Aif1p-GFP (protocol 
described in 3.9). Extracts from cells expressing pAIF1ΔNLS-GFP were used as a 
negative control for Hsp70p binding (Figure 23). 
 
 
 
 
Figure 22 – Immunodetection of Aif1p-GFP obtained by immunoprecipitation of the cytosolic fraction of 
BY4741 cells expressing pAIF1ΔMLS-GFP or pAIF1ΔNLS-GFP plasmids and ssa1Δ cells expressing 
pAIF1ΔMLS-GFP using a GFP antibody. 
 
 
 As seen in figure 22, all GFP fusions had the expected size, and 5 µg of anti-
GFP antibody immunoprecipitated the highest amount of GFP fusions. It was also 
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apparent that there was less Aif1p ΔMLS-GFP immunoprecipitated from the cytosol of 
ssa1Δ cells, as well as another band with approximately 30 kDa. This presumably 
corresponds to free GFP, resulting from partial degradation of Aif1p, again suggesting 
Aif1p requires Hsp70p binding for stability. We next determined the pattern of proteins 
interacting with Aif1p fusions in the cytosol by silver staining (Figure 23).  
 
 
 
 
 
Figure 23 – Profile of Aif1p-interacting proteins obtained by immunoprecipitation and detected by silver 
staining, in a gradient polyacrilamide gel (4-20%). Cytosol from BY4741 pAIF1ΔNLS-GFP, BY4741 
pAIF1ΔMLS-GFP and ssa1Δ pAIF1ΔMLS-GFP. 
 
 
 We could observe a large number of proteins interacting with Aif1p ΔMLS-GFP 
in both wild type and ssa1Δ cells, which showed a similar profile.  
 Western blot analysis with an anti-Ssa1p antibody would be required to 
determine whether Aif1p and Ssa1p interact in vivo.  
 There were much fewer proteins interacting with Aif1p ΔNLS-GFP, indicating 
the proteins immunoprecipitated with Aif1p ΔMLS-GFP are likely real interacting 
partners. Mass spectrometry analysis will be required to identify these proteins. 
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 Since the discovery that yeasts can commit “cell suicide”, S. cerevisiae has 
been extensively used to study apoptotic cell death, with the objective of gaining insight 
into poorly understood mechanistic aspects of mammalian apoptosis. In both 
mammalian and yeast apoptosis, mitochondria have gained great importance due to 
their ability of propagate the death signals generated within the cell, such as oxidative 
stress, DNA damage and others (Wang, 2001). Many stress stimuli can trigger MOMP 
and the release of pro-apoptotic proteins from the mitochondria to the cytosol, such as 
cytochrome c and Aif1p.   
 Cytochrome c exerts its lethal function in the cytosol, which has been well 
characterized in higher eukaryotes, but mammalian AIF needs to be translocated into 
the nucleus in order to exert its pro-apoptotic function. The mechanism underlying this 
translocation is still poorly understood, though it involves a regulated interaction with 
Hsp70p in the cytosol (Ye et al., 2002). The yeast orthologue of mammalian AIF also 
plays a role in cell death, and pure Aif1p can degrade yeast nuclei and plasmid DNA. 
Aif1p, as mammalian AIF, has a mitochondrial localization in normal cells and is 
translocated to the nucleus after an apoptotic stimulus. However, to our knowledge the 
mechanism mediating translocation of Aif1p into the nucleus has not yet been studied. 
For the majority of macromolecules, transport into the nucleus through nuclear pore 
complexes is an energy-dependent process and normally mediated by the major class 
of transport receptors, the karyopherins or Kaps. We therefore aimed to elucidate the 
mechanism regulating yeast Aif1p import into the nucleus, and determine which Kap is 
responsible for the nuclear accumulation of Aif1p. However, we were unable to 
establish a robust system to detect accumulation of Aif1p-GFP in the nucleus, and thus 
we were not able to screen the collection of yeast kapΔ mutant strains to determine 
which were defective in this process.  
 Several stimuli are described as capable of triggering apoptosis in yeast leading 
to MOMP and the release of pro-apoptotic proteins such as cyt c and Aif1p (Ludovico 
et al., 2002, Vachova and Palkova, 2005, Khoury et al., 2008, Wissing et al., 2004 and 
Priault et al., 1999). Wissing and colleagues were able to observe the translocation of 
Aif1p from the mitochondria to the nucleus by fluorescence microscopy, using a 
plasmid containing the AIF1 gene under the control of a promoter repressed by 
methionine. Unfortunately, expressing Aif1p-GFP from this plasmid requires removing 
methionine from the medium, and minimum levels of fluorescence were observed using 
the microscope (D. Trindade, personal communication). For this reason, we cloned 
Aif1p-GFP in pYX242GFP, a multi-copy plasmid, under the control of the strong TPI 
promoter (pAIF1WT-GFP). This allows the constitutive expression of Aif1p-GFP at high 
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levels. Indeed, we could observe that cells expressing this plasmid had a strong GFP 
fluorescence with mitochondrial morphology. 
 Localization of Aif1p-GFP was studied in cells expressing pAIF1WT-GFP after 
exposure to acetic acid or H2O2, or in cells undergoing chronological ageing or 
expressing Bax c-myc using fluorescence microscopy and sub-cellular 
fractionation/western blot. Chronological ageing and acetic acid treatment resulted in a 
total loss of Aif1p green fluorescence levels, presumably because both lead to an 
increase of intracellular acidification affecting fluorescence emission (not shown). For 
that reason, the fluorescence microscopy assays were only performed in cells exposed 
to H2O2 and expressing Bax c-myc and the cellular fractioning assays in cells exposed 
to acetic acid and expressing Bax c-myc protein. By fluorescence microscopy, we were 
not able to observe the release of Aif1p-GFP from the mitochondria or its translocation 
to the nucleus either in response to H2O2 exposure or to heterologous expression of 
Bax c-myc. These results suggested that MOMP was not occurring under our 
experimental conditions, or that the amount of Aif1p-GFP re-localized was much 
smaller than that remaining in the mitochondria. The signal from mitochondrial Aif1p-
GFP resulting from its high overexpression could therefore hinder detection of cytosolic 
and nuclear protein. To overcome this problem, we are in the process of tagging 
endogenous Aif1p with GFP in the genome by homologous recombination. Disrupting 
AIF1 using short flanking sequences has proven difficult (not shown), probably 
because this gene resides in a poorly accessible chromatin region, near the telomere. 
We have therefore amplified AIF1 tagged with GFP flanked by homology sequences for 
pAG61 (an integrative plasmid), and cloned it into this plasmid by Gap Repair. We are 
also in the process of cloning the 3’ UTR region of AIF1 downstream of the URA3 
marker in the same plasmid. After digestion with appropriated enzymes, this plasmid 
will work as a cassette with 1kb of homology up- and downstream of the AIF1 gene, to 
allow for more effective homologous recombination in the genome of any yeast strain. 
This strategy will allow the observation of endogenous Aif1p levels in the different 
organelles by fluorescence microscopy, without Aif1p overexpression.  
 As mentioned above, it may have been that we could not observe the release of 
Aif1p-GFP by fluorescence microscopy because MOMP was not occurring under our 
experimental conditions, or because the amount of Aif1p-GFP localizing to the nucleus 
was bellow our detection limits. For that reason, we tried to detect MOMP and the 
localization of Aif1p-GFP by sub-cellular fractionation in purified mitochondrial, 
cytosolic, and nuclear fractions. The results of the cellular fractioning and western blot 
demonstrated that there was some release of cyt c both in cells treated with acetic acid 
and in cells expressing Bax c-myc. On the other hand, Aif1p-GFP release into the 
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cytosol was not observed, suggesting that MOMP is occurring allowing the release of 
cyt c but not of Aif1p-GFP, or that the levels of MOMP achieved were very low, and 
only the earlier release of cyt c was observed. The accumulation of Aif1p-GFP in the 
nucleus was evaluated by detecting Aif1-GFP in the nuclear fraction. Yeast nuclei were 
purified using three different methods; however, it was not possible to obtain purified 
nuclei by differential centrifugation, because it was always contaminated with 
mitochondria. Consequently, the levels of Aif1p-GFP detected in the nucleus are 
probably due to the mitochondrial contaminations.  It has now been reported that Aif1p 
is translocated to the nucleus after exposure to hydrogen peroxide in only 25% of cells 
(Gruhlke et al., 2012). Therefore, we expect that detecting an enrichment of 25% at 
best of Aif1p-GFP in the nuclear fraction after treatment would not be reliable, and 
using this method to confirm accumulation of Aif1p-GFP in the nucleus would only be 
possible in case there were no traces of mitochondrial contamination in the nuclear 
fraction. Since this would be very technically challenging, we abandoned this 
methodology. 
 The major goal of this work consisted in determining which Kap is responsible 
for the transport of Aif1p to the nucleus. Our intention was to transform mutants in each 
of the yeast soluble transport receptors (Kaps) with pAIF1WT-GFP and assess the 
localization of Aif1p-GFP by fluorescence microscopy after apoptosis induction. The 
mutant with less accumulation in the nucleus would lack the Kap responsible for Aif1p 
import. However, since it is described that with an apoptotic stimulus, at best 25% of 
cells show Aif1p translocation to the nucleus, and due to the functional redundancy of 
this family, there would be the risk of not being able to observe a significant decrease 
in Aif1p-GFP accumulation in the nucleus in individual Kaps mutants. Mapping the NLS 
of Aif1p would thus overcome the need for the use of apoptotic stimuli to observe Aif1p 
translocation to the nucleus, and greatly facilitate this study.  
 The human AIF protein possesses five typical domains: an N-terminal 
Mitochondrial Localization Signal (MLS) domain; a FAD and NADH binding domain 
responsible for its oxireductase activity; an Hsp70p binding domain; a C-terminal end 
domain; and the Nuclear Localization Signal (NLS) that is located between the 
aminoacids 367 and 459 (Modjtahedi et al., 2006, Daugas et al., 2000 and Gurbuxani 
et al., 2003) (Figure 2). Taking this information into account and the homology of hAIF 
with yeast Aif1p, we cloned different AIF1 isoforms in frame with GFP where different 
domains were deleted, in order to determine the location of the Aif1p NLS (AIF1 ΔMLS, 
AIF1 ΔHSP70 and AIF1 ΔNLS). Cells transformed with the different plasmids were 
visualized by fluorescence microscopy in order to evaluate the localization of the 
different Aif1p isoforms. As expected, deletion of the MLS domain led to a change of 
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Aif1p localization from the mitochondria to the cytosol. On the other hand, deletion of 
the Hsp70p binding domain (AIF1 ΔHSP70 and AIF1 ΔNLS isoforms) led to aberrant 
localization of GFP, possibly in aggregates. Since deletion of the MLS domain did not 
result in the nuclear import of Aif1p-GFP, our results suggest that Aif1p translocation to 
the nucleus is regulated at a step subsequent to Aif1p release from the mitochondria. 
Our results also suggested that interaction with Hsp70p in the cytosol seems to be 
important for the correct folding of Aif1p, though additional experiments are required.  
 Since none of the Aif1p fragments had a nuclear localization, we could not map 
the NLS of Aif1p. It would be interesting to construct several deletions from the C-
terminal end of the gene to map the NLS. Using this strategy, deletion of the Hsp70p 
binding domain would not occur and Aif1p would not be destabilized. It would still be 
necessary to delete the MLS domain to guarantee that Aif1p would have a cytosolic 
localization, and possible an apoptotic stimulus. The location of the hAIF NLS is known, 
and directed our choice of domains to be deleted. Using further analysis of the 
homology between the two aminoacids sequences, it would be interesting to delete the 
corresponding aminoacids in Aif1p and assess if the nuclear accumulation of Aif1p is 
abolished (once we establish a solid system), in order to discover if the NLS domain is 
conserved between these organisms.  
 We cannot discard that AIF does not have a true NLS domain and that the 
transport of this protein into the nucleus is not dependent on this domain for direct 
interaction with a transport receptor, but instead is involved in a regulated mechanism 
involving other proteins, for example the Hsp70p protein. As mentioned above, Hsp70p 
protein binds to cytosolic hAIF protein and possibly to Aif1p in yeast (see below), acting 
as chaperone that helps in the folding of the protein and in it stabilization. The NLS 
domain of a protein is a necessary and sufficient domain to promote translocation of 
the protein to the nucleus. Since deletion of the MLS did not lead to nuclear import of 
Aif1p, we hypothesize that either Aif1p has an NLS that is masked and/or regulated by 
additional proteins, or that Aif1p does not have this domain. It is therefore likely that 
AIF1 ΔMLS only translocates to the nucleus after apoptotic stimuli. Aif1p and hAIF 
proteins possess several similarities in terms of structure, function and mode of action, 
It would thus be interesting to test whether heterologous expression of hAIF protein in 
yeast complements the phenotype of an aif1Δ mutant and whether hAIF-GFP 
translocates to the nucleus after an apoptotic stimulus (Candé et al., 2002). It would be 
also interesting to express other hAIF isoforms (described by Gurbuxani et al., 2003) to 
determine if they have the same localization and phenotype when expressed in yeast 
cells. Once the Kap(s) responsible for Aif1p nuclear accumulation is identified, it would 
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be interesting to determine if the same Kap is responsible for hAIF import to the 
nucleus. 
 
 Hsp70p is described as being capable of regulating apoptosis. This protein is 
involved mostly in the inhibition of apoptosis by blocking Apaf-1/formation of the 
apoptosome or by stabilization of AIF protein in the cytosol, inhibiting nuclear 
accumulation of this protein, and thus leading to inhibition of DNA degradation in the 
nucleus. This protein has been associated with a cytoprotective role against the 
apoptogenic effects of AIF targeted to the extramitochondrial compartment, as its 
down-regulation facilitates the induction of apoptosis, whereas its up-regulation leads 
to inhibition of apoptosis (Ravagnan et al., 2001). Deletion of Hsp70p binding domain 
(residues 150 to 228) leads to a gain of function phenotype, i.e., facilitates the nuclear 
translocation of AIF. As mentioned previously, in the course of trying to map the NLS 
domain of Aif1p, we observed the formation of green fluorescent aggregate-like 
structures in Aif1p constructs lacking the sequence homologous to the hAIF Hsp70-
binding domain, suggesting that yeast Aif1p interacts with Hsp70p. We also observed 
that cytosolic Aif1p with an intact Hsp70p binding domain localized to aberrant green 
fluorescent spots in yeast cells lacking Hsp70p protein. This corroborates the idea that 
binding of Hsp70p protein to Aif1p is required for stabilization and folding of Aif1p and 
suggests another role of the yeast Hsp70p in the function of Aif1p. We hypothesize 
that, in the absence of Hsp70p protein or when its Hsp70p binding domain is deleted, 
cytosolic Aif1p becomes misfolded or unfolded, probably loosing its normal function.  
 Several stressors lead to misfolded or unfolded proteins, but cells normally 
ensure that proteins are folded correctly using a variety of chaperones, foldases or 
lectins. When proteins cannot be restored, misfolded proteins are targeted for 
processing or degradation (Chakrabarti et al., 2011). In yeasts, there are two major 
pathways described for protein degradation; the vacuolar pathway and the proteasome 
pathway. Since AIF1 ∆HSP70 forms spots, possible aggregates, it is possible that 
Aif1p ΔHSP70-GFP is misfolded and should therefore be partly degraded by one of the 
degradation pathways. Degradation by the vacuolar pathway does not seem to be 
occurring in these cells, because the green fluorescent aggregates do not seem to 
have a vacuolar localization. However, to confirm the exact location of the aggregates, 
cells expressing the pAIF1ΔHSP70-GFP and pAIF1ΔNLS-GFP plasmids should be 
stained with Arg-CMAC, a label for the lumen of the vacuole. On the other hand, 
aggregates could correspond to Aif1p-GFP inside of autophagosomes formed during 
autophagy. Autophagy is the mechanism by which cells use parts of themselves to 
survive starvation and stress, limiting cell death by recycling energy and substrates, 
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and removing damaged proteins and organelles. This autophagic process begins with 
the formation of a double membrane, the autophagosome. This structure envelops 
cytoplasmatic content and then fuses with the lysosome/vacuole, releasing the inner 
content of the vesicle for degradation, recycling in this way the cell’s own damaged 
intracellular machinery. This way, cells can maintain homeostasis during starvation and 
stress situations. (Codogno and Meijer, 2005 and Hotchkiss et al., 2009) (Figure 24). 
Aif1p ΔHSP70-GFP as a misfolded protein could be incorporated into the 
autophagosome in order to be degraded. To test this hypothesis, a western blot can be 
performed with samples from cells expressing pAIF1ΔHSP70-GFP and pAIF1ΔNLS-
GFP to determine the occurrence of autophagy by detecting markers such as 
accumulation of Atg8p or Atg2p. However, we could not detect any GFP fluorescence 
in the vacuole, and GFP is normally resistant to degradation in the vacuole (a fact that 
forms the basis for several autophagy-detecting assays), and thus this hypothesis is 
unlikely. 
 Another scenario for misfolded/unfolded 
proteins is the formation of specialized 
structures, the aggresomes. These structures 
result from a saturation of the levels of 
misfolded/unfolded proteins in the normal 
proteolytic machinery, which accumulate as 
ubiquitinated inclusions near the centrosome 
(Kopito, 2000). Formation of aggresomes was 
also described in yeast cells (Saliba et al., 2002 
and Wang et al., 2009). The localization pattern 
of aggresomes is similar to that we observed 
for Aif1p lacking the putative Hsp70p binding 
domain. To determine whether we are 
observing aggresomes in cells expressing 
pAIF1ΔHSP70-GFP and pAIF1ΔNLS-GFP, it 
would be interesting to incubate cells with 
MG132, a proteasome inhibitor that increases 
the formation of aggresomes (Saliba et al., 
2002). Another approach would be performing 
co-localization studies of the “aggregates” with 
the spindle pole body (SPB), the prototype of the centrosome in yeast, because 
normally the aggresomes are located near the centrosome. For this purpose, we could 
Figure 24 - Representation of the 
molecular and morphological processes 
associated with autophagy (Hotchkiss et 
al., 2009) 
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use cells expressing BFP-tagged components of the SPB (Wang et al., 2009 and 
Moens et al., 1971). 
 
 To uncover which proteins interact with Aif1p-GFP in the cytosol, we performed 
an immunoprecipitation of the cytosol from cells expressing the pAIF1ΔMLS and 
pAIF1ΔNLS (control) (Figure 23). Our results show that the Aif1 ΔMLS protein 
specifically interacts with multiple proteins in the cytosol (as the most 
immunoprecipitated proteins do not interact with the Aif1 ΔNLS protein). Taken 
together, our results thus suggested that Aif1p interacts specifically with several 
proteins in the cytosol, including with the Hsp70p protein. To confirm the interaction of 
Aif1p with Hsp70p protein, we will next detect the presence of Hsp70p in the 
immunoprecipitated fraction with an antibody against Ssa1 (Hsp70p). We will next 
optimize this protocol in order to identify Aif1p-interacting proteins by mass 
spectrometry, both in cytosolic extracts from cells without and with an apoptotic 
stimulus. We will first elute interacting proteins with a salt gradient to distinguish which 
bands represent proteins with a strong interaction with cytosolic Aif1p, and to 
determine the salt concentration for which we eliminate most unspecific bands. Bands 
and/or the elution fractions can then be analyzed by mass spectrometry for protein 
identification. Identification of proteins that interact with cytosolic Aif1p before and after 
an apoptotic stimulus should provide valuable insight into the regulation of this protein 
and its pro-apoptotic effect.  
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